Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:ortho-fused heteroarene
go back to main search page
Accession:CHEBI:52362 term browser browse the term
Definition:An ortho-fused compound in which at least one of the rings contains at least one heteroatom.
Synonyms:related_synonym: ortho-fused heteroarenes


show annotations for term's descendants           Sort by:
 
1H-indole term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Ahr aryl hydrocarbon receptor multiple interactions ISO indole binds to and results in increased activity of AHR protein; indole results in increased activity of [AHR protein binds to ARNT protein] CTD PMID:9407059, PMID:28186253 NCBI chr 6:54,963,990...55,001,806
Ensembl chr 6:54,963,990...55,001,464
JBrowse link
G Arnt aryl hydrocarbon receptor nuclear translocator multiple interactions ISO indole results in increased activity of [AHR protein binds to ARNT protein] CTD PMID:9407059 NCBI chr 2:196,594,178...196,651,486
Ensembl chr 2:196,594,303...196,651,179
JBrowse link
G Epo erythropoietin multiple interactions EXP indole inhibits the reaction [cobaltous chloride results in increased expression of EPO mRNA]; indole inhibits the reaction [cobaltous chloride results in increased expression of EPO protein] CTD PMID:21863063 NCBI chr12:22,274,828...22,278,268
Ensembl chr12:22,274,828...22,278,266
JBrowse link
G Mc1r melanocortin 1 receptor affects binding ISO indole analog binds to MC1R protein CTD PMID:11909711 NCBI chr19:56,215,420...56,219,987 JBrowse link
G Mc3r melanocortin 3 receptor affects binding ISO indole analog binds to MC3R protein CTD PMID:11909711 NCBI chr 3:170,252,901...170,253,998
Ensembl chr 3:170,252,901...170,253,998
JBrowse link
G Mc4r melanocortin 4 receptor affects binding ISO indole analog binds to MC4R protein CTD PMID:11909711 NCBI chr18:62,612,838...62,614,725
Ensembl chr18:62,612,838...62,614,725
JBrowse link
G Mc5r melanocortin 5 receptor affects binding ISO indole analog binds to MC5R protein CTD PMID:11909711 NCBI chr18:64,113,659...64,118,700
Ensembl chr18:64,114,933...64,116,524
JBrowse link
2-methyl-1H-indole term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcb1a ATP binding cassette subfamily B member 1A increases expression ISO 2-methylindole results in increased expression of ABCB1 mRNA CTD PMID:32092453 NCBI chr 4:22,339,829...22,517,642
Ensembl chr 4:22,133,521...22,425,515
JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 increases expression
multiple interactions
ISO 2-methylindole results in increased expression of CYP1A1 protein
2-methylindole inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein]
CTD PMID:31201936 NCBI chr 8:62,472,087...62,478,122
Ensembl chr 8:62,472,095...62,478,147
JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 increases expression ISO 2-methylindole results in increased expression of CYP1A2 protein CTD PMID:31201936 NCBI chr 8:62,451,360...62,458,244
Ensembl chr 8:62,451,329...62,458,301
JBrowse link
G Nr1i2 nuclear receptor subfamily 1, group I, member 2 affects binding
multiple interactions
increases expression
ISO 2-methylindole binds to NR1I2 protein
NR1I2 protein affects the reaction [2-methylindole results in increased expression of CYP3A4 mRNA]
2-methylindole results in increased expression of NR1I2 mRNA
CTD PMID:32092453 NCBI chr11:65,022,100...65,058,546
Ensembl chr11:65,022,100...65,058,545
JBrowse link
6,7-dimethoxy-2-phenylquinoxaline term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Akt1 AKT serine/threonine kinase 1 multiple interactions ISO 6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [PDGFB protein results in increased phosphorylation of AKT1 protein] CTD PMID:25896968 NCBI chr 6:137,218,398...137,239,970
Ensembl chr 6:137,218,376...137,236,258
JBrowse link
G Mapk1 mitogen activated protein kinase 1 multiple interactions ISO 6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [PDGFB protein results in increased phosphorylation of MAPK1 protein] CTD PMID:25896968 NCBI chr11:88,203,863...88,273,301
Ensembl chr11:88,211,599...88,273,254
JBrowse link
G Mapk3 mitogen activated protein kinase 3 multiple interactions ISO 6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [PDGFB protein results in increased phosphorylation of MAPK3 protein] CTD PMID:25896968 NCBI chr 1:198,192,773...198,198,975
Ensembl chr 1:198,192,773...198,198,975
JBrowse link
G Pdgfb platelet derived growth factor subunit B multiple interactions ISO 6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [Nicotine results in increased expression of PDGFB mRNA]; 6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [Nicotine results in increased secretion of PDGFB protein]; 6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [PDGFB protein results in increased phosphorylation of AKT1 protein]; 6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [PDGFB protein results in increased phosphorylation of MAPK1 protein]; 6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [PDGFB protein results in increased phosphorylation of MAPK3 protein]; 6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [PDGFB protein results in increased phosphorylation of PDGFRB protein]; 6,7-dimethoxy-2-phenylquinoxaline results in decreased susceptibility to [PDGFB protein binds to PDGFB protein] CTD PMID:16149045, PMID:23457620, PMID:25896968 NCBI chr 7:121,215,458...121,233,092
Ensembl chr 7:121,214,628...121,232,741
JBrowse link
G Pdgfrb platelet derived growth factor receptor beta multiple interactions ISO 6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [Nicotine results in increased expression of PDGFRB protein]; 6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [PDGFB protein results in increased phosphorylation of PDGFRB protein] CTD PMID:16149045, PMID:25896968 NCBI chr18:56,364,586...56,406,381
Ensembl chr18:56,364,620...56,406,381
JBrowse link
6-Cyano-7-nitroquinoxaline-2,3-dione term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Aco2 aconitase 2 multiple interactions EXP 6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [Kainic Acid results in decreased activity of ACO2 protein] CTD PMID:11520895 NCBI chr 7:123,102,493...123,145,608
Ensembl chr 7:123,102,468...123,145,635
JBrowse link
G Bdnf brain-derived neurotrophic factor multiple interactions EXP 6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [Pilocarpine results in increased expression of BDNF mRNA alternative form] CTD PMID:15183516 NCBI chr 3:100,768,637...100,819,216
Ensembl chr 3:100,768,637...100,819,210
JBrowse link
G Casp3 caspase 3 multiple interactions EXP 6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid inhibits the reaction [Phencyclidine results in increased activity of CASP3 protein]] CTD PMID:24995437 NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
JBrowse link
G Fos Fos proto-oncogene, AP-1 transcription factor subunit multiple interactions EXP 6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [Capsaicin results in increased expression of FOS] CTD PMID:10401552 NCBI chr 6:109,300,433...109,303,299
Ensembl chr 6:109,300,433...109,303,299
JBrowse link
G Gfap glial fibrillary acidic protein multiple interactions EXP 6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [diphenylditelluride results in decreased phosphorylation of GFAP protein] CTD PMID:21863293 NCBI chr10:90,990,762...90,999,435
Ensembl chr10:90,990,762...90,999,506
JBrowse link
G Gria1 glutamate ionotropic receptor AMPA type subunit 1 multiple interactions EXP 6-Cyano-7-nitroquinoxaline-2,3-dione results in increased expression of and results in increased localization of GRIA1 protein CTD PMID:19674091 NCBI chr10:42,441,723...42,760,200
Ensembl chr10:42,614,713...42,760,200
JBrowse link
G Gria2 glutamate ionotropic receptor AMPA type subunit 2 multiple interactions EXP 6-Cyano-7-nitroquinoxaline-2,3-dione results in increased expression of and results in increased localization of GRIA2 protein CTD PMID:19674091 NCBI chr 2:179,584,302...179,704,629
Ensembl chr 2:179,584,308...179,704,629
JBrowse link
G Mapk1 mitogen activated protein kinase 1 multiple interactions ISO
EXP
6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein]
6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [Capsaicin results in increased phosphorylation of MAPK1 protein]
CTD PMID:15385614, PMID:19850060 NCBI chr11:88,203,863...88,273,301
Ensembl chr11:88,211,599...88,273,254
JBrowse link
G Mapk3 mitogen activated protein kinase 3 multiple interactions ISO
EXP
6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK3 protein]
6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [Capsaicin results in increased phosphorylation of MAPK3 protein]
CTD PMID:15385614, PMID:19850060 NCBI chr 1:198,192,773...198,198,975
Ensembl chr 1:198,192,773...198,198,975
JBrowse link
G Nefl neurofilament light multiple interactions EXP 6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [diphenylditelluride results in decreased phosphorylation of NEFL protein] CTD PMID:21863293 NCBI chr15:44,799,378...44,803,251
Ensembl chr15:44,799,334...44,804,574
JBrowse link
G Nefm neurofilament medium multiple interactions EXP 6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [diphenylditelluride results in decreased phosphorylation of NEFM protein] CTD PMID:21863293 NCBI chr15:44,855,307...44,860,604
Ensembl chr15:44,855,310...44,860,604
JBrowse link
G Sct secretin multiple interactions EXP 6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [SCT protein results in increased secretion of gamma-Aminobutyric Acid] CTD PMID:15963647 NCBI chr 1:214,264,865...214,277,437
Ensembl chr 1:214,264,754...214,265,668
JBrowse link
G Tac1 tachykinin, precursor 1 multiple interactions EXP 6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [L 703606 results in increased activity of TAC1 protein] CTD PMID:14985054 NCBI chr 4:33,638,853...33,646,819
Ensembl chr 4:33,638,709...33,646,819
JBrowse link
G Vim vimentin multiple interactions EXP 6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [diphenylditelluride results in decreased phosphorylation of VIM protein] CTD PMID:21863293 NCBI chr17:80,882,715...80,891,200
Ensembl chr17:80,882,666...80,891,212
JBrowse link
brimonidine tartrate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Adra2a adrenoceptor alpha 2A multiple interactions ISO
EXP
Brimonidine Tartrate inhibits the reaction [Norepinephrine binds to and results in increased activity of ADRA2A protein]; Brimonidine Tartrate promotes the reaction [Phenylephrine binds to and results in increased activity of ADRA2A protein]; Phenylephrine promotes the reaction [Brimonidine Tartrate binds to and results in increased activity of ADRA2A protein]; Prazosin inhibits the reaction [Phenylephrine promotes the reaction [Brimonidine Tartrate binds to and results in increased activity of ADRA2A protein]]; Yohimbine inhibits the reaction [Brimonidine Tartrate promotes the reaction [Phenylephrine binds to and results in increased activity of ADRA2A protein]] CTD PMID:8397342, PMID:10742289, PMID:12208771, PMID:12598592 NCBI chr 1:274,766,283...274,769,083
Ensembl chr 1:274,766,283...274,769,081
JBrowse link
G Agt angiotensinogen multiple interactions EXP 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased abundance of Superoxides]]; 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased expression of RHOA protein]]; 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased abundance of Superoxides]]; 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased expression of RHOA protein]]; bisindolylmaleimide I inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased abundance of Superoxides]]; bisindolylmaleimide I inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased expression of RHOA protein]]; Brimonidine Tartrate promotes the reaction [AGT protein results in increased abundance of Superoxides]; Brimonidine Tartrate promotes the reaction [AGT protein results in increased activity of RHOA protein]; diphenyleneiodonium inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased abundance of Superoxides]]; diphenyleneiodonium inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased expression of RHOA protein]]; tempol inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased abundance of Superoxides]]; tempol inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased expression of RHOA protein]] CTD PMID:18250367 NCBI chr19:57,321,594...57,333,460
Ensembl chr19:57,321,640...57,333,433
JBrowse link
G Cftr CF transmembrane conductance regulator multiple interactions ISO Brimonidine Tartrate inhibits the reaction [CFTR protein affects the transport of Chlorides] CTD PMID:12598592 NCBI chr 4:42,693,263...42,860,679
Ensembl chr 4:42,692,836...42,860,676
JBrowse link
G Creb1 cAMP responsive element binding protein 1 increases phosphorylation EXP Brimonidine Tartrate results in increased phosphorylation of CREB1 protein CTD PMID:17680988 NCBI chr 9:71,229,753...71,298,994
Ensembl chr 9:71,230,108...71,293,435
JBrowse link
G Prkca protein kinase C, alpha affects localization
multiple interactions
EXP Brimonidine Tartrate affects the localization of PRKCA protein
Nitric Oxide deficiency promotes the reaction [Brimonidine Tartrate affects the localization of PRKCA protein]
CTD PMID:12388232 NCBI chr10:96,186,509...96,585,168
Ensembl chr10:96,191,133...96,584,947
JBrowse link
G Prkcd protein kinase C, delta affects localization
multiple interactions
EXP Brimonidine Tartrate affects the localization of PRKCD protein
Nitric Oxide deficiency inhibits the reaction [Brimonidine Tartrate affects the localization of PRKCD protein]
CTD PMID:12388232 NCBI chr16:6,655,131...6,675,746
Ensembl chr16:6,655,120...6,675,746
JBrowse link
G Rhoa ras homolog family member A multiple interactions EXP 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased expression of RHOA protein]]; 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased expression of RHOA protein]]; bisindolylmaleimide I inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased expression of RHOA protein]]; Brimonidine Tartrate promotes the reaction [AGT protein results in increased activity of RHOA protein]; diphenyleneiodonium inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased expression of RHOA protein]]; tempol inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased expression of RHOA protein]] CTD PMID:18250367 NCBI chr 8:117,082,440...117,116,244
Ensembl chr 8:117,106,576...117,116,167
JBrowse link
G Slc22a2 solute carrier family 22 member 2 multiple interactions ISO Brimonidine Tartrate inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 NCBI chr 1:48,318,025...48,360,219
Ensembl chr 1:48,317,995...48,360,261
JBrowse link
cyclazosin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Adra1b adrenoceptor alpha 1B multiple interactions EXP cyclazosin binds to and results in decreased activity of ADRA1B protein CTD PMID:15951348 NCBI chr10:29,392,762...29,450,644
Ensembl chr10:29,392,762...29,450,644
JBrowse link
enoxacin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 multiple interactions
affects binding
decreases activity
ISO
EXP
Enoxacin inhibits the reaction [CYP1A2 protein affects the metabolism of Fluvoxamine]; Enoxacin inhibits the reaction [CYP1A2 protein results in increased metabolism of Tacrine]; NADP promotes the reaction [Enoxacin inhibits the reaction [CYP1A2 protein results in increased metabolism of Tacrine]]
Enoxacin inhibits the reaction [CYP1A2 protein results in increased metabolism of Phenacetin]
Enoxacin binds to CYP1A2 protein
Enoxacin results in decreased activity of CYP1A2 protein
CTD PMID:7946932, PMID:8905919, PMID:15905806 NCBI chr 8:62,451,360...62,458,244
Ensembl chr 8:62,451,329...62,458,301
JBrowse link
G Gstp1 glutathione S-transferase pi 1 multiple interactions ISO Enoxacin inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate] CTD PMID:23769903 NCBI chr 1:219,291,679...219,294,147
Ensembl chr 1:219,291,679...219,294,147
JBrowse link
G Nos1 nitric oxide synthase 1 multiple interactions ISO 7-nitroindazole inhibits the reaction [[Enoxacin co-treated with fenbufen] results in increased activity of NOS1 protein]; [Enoxacin co-treated with fenbufen] results in increased activity of NOS1 protein CTD PMID:9623721 NCBI chr12:44,214,949...44,405,530
Ensembl chr12:44,213,943...44,520,341
JBrowse link
hydralazine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcb5 ATP binding cassette subfamily B member 5 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of ABCB5 mRNA CTD PMID:17183730 NCBI chr 6:146,805,481...146,902,339
Ensembl chr 6:146,805,599...146,902,339
JBrowse link
G Acaa1a acetyl-CoA acyltransferase 1A multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ACAA1 mRNA CTD PMID:17183730 NCBI chr 8:128,027,880...128,036,471
Ensembl chr 8:128,027,958...128,036,236
JBrowse link
G Acad9 acyl-CoA dehydrogenase family, member 9 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ACAD9 mRNA CTD PMID:17183730 NCBI chr 2:122,782,051...122,806,166
Ensembl chr 2:122,782,060...122,805,768
JBrowse link
G Acat2 acetyl-CoA acetyltransferase 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ACAT2 mRNA CTD PMID:17183730 NCBI chr 1:47,972,399...47,992,654
Ensembl chr 1:47,972,399...47,992,653
JBrowse link
G Ace angiotensin I converting enzyme multiple interactions EXP Hydralazine inhibits the reaction [Nitric Oxide deficiency results in increased expression of ACE mRNA] CTD PMID:16326922 NCBI chr10:94,170,766...94,213,831
Ensembl chr10:94,170,766...94,187,822
JBrowse link
G Acin1 apoptotic chromatin condensation inducer 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ACIN1 mRNA CTD PMID:17183730 NCBI chr15:33,288,369...33,333,256
Ensembl chr15:33,288,374...33,333,417
JBrowse link
G Acot2 acyl-CoA thioesterase 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of ACOT2 mRNA CTD PMID:17183730 NCBI chr 6:107,460,596...107,468,324
Ensembl chr 6:107,460,668...107,467,487
JBrowse link
G Acta1 actin, alpha 1, skeletal muscle multiple interactions EXP Hydralazine inhibits the reaction [Nitric Oxide deficiency results in increased expression of ACTA1 mRNA] CTD PMID:16326922 NCBI chr19:56,674,072...56,677,084
Ensembl chr19:56,674,074...56,677,084
JBrowse link
G Adamts10 ADAM metallopeptidase with thrombospondin type 1 motif, 10 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ADAMTS10 mRNA CTD PMID:17183730 NCBI chr 7:18,409,147...18,439,012
Ensembl chr 7:18,409,147...18,439,012
JBrowse link
G Adgra3 adhesion G protein-coupled receptor A3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ADGRA3 mRNA CTD PMID:17183730 NCBI chr14:64,686,677...64,786,813
Ensembl chr14:64,686,793...64,786,497
JBrowse link
G Adipor1 adiponectin receptor 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ADIPOR1 mRNA CTD PMID:17183730 NCBI chr13:51,240,470...51,260,233
Ensembl chr13:51,240,911...51,260,228
JBrowse link
G Adsl adenylosuccinate lyase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ADSL mRNA CTD PMID:17183730 NCBI chr 7:122,157,201...122,192,328
Ensembl chr 7:122,157,201...122,192,328
JBrowse link
G Afg3l2 AFG3 like matrix AAA peptidase subunit 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of AFG3L2 mRNA CTD PMID:17183730 NCBI chr18:63,141,418...63,185,510
Ensembl chr18:63,141,418...63,185,510
JBrowse link
G Agk acylglycerol kinase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of AGK mRNA CTD PMID:17183730 NCBI chr 4:68,483,345...68,561,518
Ensembl chr 4:68,483,320...68,560,801
JBrowse link
G Agpat2 1-acylglycerol-3-phosphate O-acyltransferase 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of AGPAT2 mRNA CTD PMID:17183730 NCBI chr 3:4,044,741...4,055,384
Ensembl chr 3:4,044,542...4,055,806
JBrowse link
G Agt angiotensinogen multiple interactions
decreases response to substance
EXP
ISO
Hydralazine affects the reaction [AGT protein results in increased abundance of Fatty Acids, Nonesterified]; Hydralazine affects the reaction [AGT protein results in increased abundance of Triglycerides]; Hydralazine inhibits the reaction [AGT protein affects the abundance of Cholesterol]; Hydralazine inhibits the reaction [AGT protein modified form results in increased phosphorylation of MAPK1 protein]; Hydralazine inhibits the reaction [AGT protein modified form results in increased phosphorylation of MAPK3 protein]; Hydralazine inhibits the reaction [AGT protein results in decreased expression of CPT1A mRNA]
Hydralazine results in decreased susceptibility to AGT protein modified form
CTD PMID:16344371, PMID:19109942, PMID:21289285 NCBI chr19:57,321,594...57,333,460
Ensembl chr19:57,321,640...57,333,433
JBrowse link
G Akr1a1 aldo-keto reductase family 1 member A1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of AKR1A1 mRNA CTD PMID:17183730 NCBI chr 5:135,482,068...135,498,693
Ensembl chr 5:135,482,068...135,498,822
JBrowse link
G Akr1c1 aldo-keto reductase family 1, member C1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of AKR1C4 mRNA CTD PMID:17183730 NCBI chr17:69,441,253...69,460,334
Ensembl chr17:69,441,223...69,460,321
JBrowse link
G Akr1c2 aldo-keto reductase family 1, member C2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of AKR1C2 mRNA CTD PMID:17183730 NCBI chr17:69,388,337...69,435,160
Ensembl chr17:69,388,335...69,404,341
JBrowse link
G Akt2 AKT serine/threonine kinase 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of AKT2 mRNA CTD PMID:17183730 NCBI chr 1:84,400,939...84,451,223
Ensembl chr 1:84,411,726...84,450,162
JBrowse link
G Alb albumin multiple interactions
affects binding
ISO Hydralazine inhibits the reaction [[Acrolein binds to ALB protein] which results in increased expression of HMOX1 mRNA]
Hydralazine binds to [Acrolein binds to ALB protein]
CTD PMID:32530271 NCBI chr14:19,176,275...19,191,793
Ensembl chr14:19,176,277...19,191,863
JBrowse link
G Aldh18a1 aldehyde dehydrogenase 18 family, member A1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ALDH18A1 mRNA CTD PMID:17183730 NCBI chr 1:259,641,673...259,674,521
Ensembl chr 1:259,641,676...259,674,425
Ensembl chr 1:259,641,676...259,674,425
JBrowse link
G Aldh9a1 aldehyde dehydrogenase 9 family, member A1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ALDH9A1 mRNA CTD PMID:17183730 NCBI chr13:85,580,828...85,597,497
Ensembl chr13:85,580,828...85,597,493
JBrowse link
G Alox15 arachidonate 15-lipoxygenase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of ALOX15 mRNA CTD PMID:17183730 NCBI chr10:56,953,692...56,962,145
Ensembl chr10:56,953,691...56,962,161
JBrowse link
G Anapc11 anaphase promoting complex subunit 11 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ANAPC11 mRNA CTD PMID:17183730 NCBI chr10:109,774,779...109,785,877
Ensembl chr10:109,774,878...109,785,877
JBrowse link
G Ankfn1 ankyrin-repeat and fibronectin type III domain containing 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ANKFN1 mRNA CTD PMID:17183730 NCBI chr10:76,901,681...77,210,042
Ensembl chr10:76,903,325...76,930,631
JBrowse link
G Ankhd1 ankyrin repeat and KH domain containing 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ANKHD1 mRNA CTD PMID:17183730 NCBI chr18:29,386,906...29,485,611
Ensembl chr18:29,386,809...29,492,718
JBrowse link
G Ankib1 ankyrin repeat and IBR domain containing 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ANKIB1 mRNA CTD PMID:17183730 NCBI chr 4:27,473,477...27,597,206
Ensembl chr 4:27,473,477...27,597,206
JBrowse link
G Ankrd44 ankyrin repeat domain 44 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ANKRD44 mRNA CTD PMID:17183730 NCBI chr 9:61,229,252...61,529,532
Ensembl chr 9:61,231,988...61,528,882
JBrowse link
G Anxa2 annexin A2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ANXA2 mRNA CTD PMID:17183730 NCBI chr 8:75,687,134...75,723,589
Ensembl chr 8:75,687,100...75,723,594
JBrowse link
G Aoah acyloxyacyl hydrolase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of AOAH mRNA CTD PMID:17183730 NCBI chr17:45,872,414...46,115,026
Ensembl chr17:45,872,414...46,115,004
JBrowse link
G Aoc1 amine oxidase, copper containing 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of AOC1 mRNA CTD PMID:17183730 NCBI chr 4:78,496,043...78,515,582
Ensembl chr 4:78,496,043...78,515,584
JBrowse link
G Apc APC regulator of WNT signaling pathway decreases methylation ISO Hydralazine results in decreased methylation of APC promoter CTD PMID:15862127 NCBI chr18:27,011,710...27,106,323
Ensembl chr18:27,047,382...27,105,531
JBrowse link
G Apcdd1l APC down-regulated 1 like multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of APCDD1L mRNA CTD PMID:17183730 NCBI chr 3:171,879,728...171,958,155
Ensembl chr 3:171,878,143...171,957,996
JBrowse link
G Arcn1 archain 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ARCN1 mRNA CTD PMID:17183730 NCBI chr 8:49,051,257...49,075,861
Ensembl chr 8:49,051,246...49,075,892
JBrowse link
G Arf1 ADP-ribosylation factor 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ARF1 mRNA CTD PMID:17183730 NCBI chr10:45,562,700...45,579,214
Ensembl chr10:45,563,547...45,579,029
JBrowse link
G Arhgap23 Rho GTPase activating protein 23 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ARHGAP23 mRNA CTD PMID:17183730 NCBI chr10:85,387,219...85,445,805
Ensembl chr10:85,384,881...85,444,556
JBrowse link
G Arhgap40 Rho GTPase activating protein 40 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ARHGAP40 mRNA CTD PMID:17183730 NCBI chr 3:154,996,685...155,042,199
Ensembl chr 3:154,996,750...155,041,816
JBrowse link
G Arhgap5 Rho GTPase activating protein 5 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ARHGAP5 mRNA CTD PMID:17183730 NCBI chr 6:73,345,129...73,408,304
Ensembl chr 6:73,345,392...73,405,880
JBrowse link
G Arhgef12 Rho guanine nucleotide exchange factor 12 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ARHGEF12 mRNA CTD PMID:17183730 NCBI chr 8:47,259,377...47,393,042
Ensembl chr 8:47,259,404...47,393,503
JBrowse link
G Arih2 ariadne RBR E3 ubiquitin protein ligase 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ARIH2 mRNA CTD PMID:17183730 NCBI chr 8:117,387,004...117,446,085
Ensembl chr 8:117,387,010...117,446,019
JBrowse link
G Arl2 ADP-ribosylation factor like GTPase 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ARL2 mRNA CTD PMID:17183730 NCBI chr 1:221,504,150...221,516,191
Ensembl chr 1:221,504,170...221,516,110
JBrowse link
G Arl6ip5 ADP-ribosylation factor like GTPase 6 interacting protein 5 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ARL6IP5 mRNA CTD PMID:17183730 NCBI chr 4:129,574,363...129,598,240
Ensembl chr 4:129,574,264...129,598,915
JBrowse link
G Art4 ADP-ribosyltransferase 4 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ART4 mRNA CTD PMID:17183730 NCBI chr 4:170,830,851...170,841,187
Ensembl chr 4:170,830,851...170,841,187
JBrowse link
G Asap3 ArfGAP with SH3 domain, ankyrin repeat and PH domain 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of DDEFL1 mRNA CTD PMID:17183730 NCBI chr 5:154,551,901...154,596,125
Ensembl chr 5:154,552,195...154,594,785
JBrowse link
G Asb7 ankyrin repeat and SOCS box-containing 7 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ASB7 mRNA CTD PMID:17183730 NCBI chr 1:127,545,671...127,599,257
Ensembl chr 1:127,554,785...127,599,257
JBrowse link
G Asic4 acid sensing ion channel subunit family member 4 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ASIC4 mRNA CTD PMID:17183730 NCBI chr 9:82,647,071...82,668,920
Ensembl chr 9:82,647,071...82,668,920
JBrowse link
G Asph aspartate-beta-hydroxylase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ASPH mRNA CTD PMID:17183730 NCBI chr 5:22,577,680...22,799,333
Ensembl chr 5:22,577,675...22,799,349
JBrowse link
G Atf3 activating transcription factor 3 multiple interactions ISO Hydralazine inhibits the reaction [Ethanol results in increased expression of ATF3 mRNA] CTD PMID:28119953 NCBI chr13:109,817,892...109,849,632
Ensembl chr13:109,817,728...109,849,632
JBrowse link
G Atf4 activating transcription factor 4 multiple interactions ISO Hydralazine inhibits the reaction [Ethanol results in increased expression of ATF4 mRNA] CTD PMID:28119953 NCBI chr 7:121,480,723...121,482,781
Ensembl chr 7:121,480,723...121,482,772
JBrowse link
G Atg10 autophagy related 10 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ATG10 mRNA CTD PMID:17183730 NCBI chr 2:19,853,546...20,152,918
Ensembl chr 2:19,853,546...20,152,884
JBrowse link
G Atp13a4 ATPase 13A4 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ATP13A4 mRNA CTD PMID:17183730 NCBI chr11:74,833,824...74,968,160
Ensembl chr11:74,834,050...74,968,336
JBrowse link
G Atp5f1e ATP synthase F1 subunit epsilon multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ATP5F1E mRNA CTD PMID:17183730 NCBI chr 3:172,563,105...172,566,007
Ensembl chr 3:172,563,105...172,566,010
JBrowse link
G Atp5mc3 ATP synthase membrane subunit c locus 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ATP5MC3 mRNA CTD PMID:17183730 NCBI chr 3:60,811,218...60,813,903
Ensembl chr 3:60,811,210...60,813,869
JBrowse link
G Atp5me ATP synthase membrane subunit e multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ATP5ME mRNA CTD PMID:17183730 NCBI chr14:2,325,308...2,326,436
Ensembl chr14:2,325,308...2,326,436
JBrowse link
G Atp5pf ATP synthase peripheral stalk subunit F6 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ATP5PF mRNA CTD PMID:17183730 NCBI chr11:24,286,806...24,294,419
Ensembl chr11:24,286,787...24,294,179
JBrowse link
G Atp6ap1 ATPase H+ transporting accessory protein 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ATP6AP1 mRNA CTD PMID:17183730 NCBI chr  X:156,407,973...156,415,053
Ensembl chr  X:156,407,937...156,415,145
JBrowse link
G Atp6v1b1 ATPase H+ transporting V1 subunit B1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ATP6V1B1 mRNA CTD PMID:17183730 NCBI chr 4:115,417,100...115,435,754
Ensembl chr 4:115,416,580...115,437,206
JBrowse link
G Atp6v1c1 ATPase H+ transporting V1 subunit C1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ATP6V1C1 mRNA CTD PMID:17183730 NCBI chr 7:77,678,853...77,716,658
Ensembl chr 7:77,678,968...77,716,408
JBrowse link
G Atxn2 ataxin 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ATXN2 mRNA CTD PMID:17183730 NCBI chr12:40,264,601...40,335,637
Ensembl chr12:40,266,662...40,332,612
JBrowse link
G Atxn7l1 ataxin 7-like 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ATXN7L1 mRNA CTD PMID:17183730 NCBI chr 6:52,459,930...52,680,552
Ensembl chr 6:52,459,946...52,675,574
JBrowse link
G Aurkaip1 aurora kinase A interacting protein 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of AURKAIP1 mRNA CTD PMID:17183730 NCBI chr 5:173,274,433...173,276,170
Ensembl chr 5:173,256,637...173,276,169
JBrowse link
G B9d1 B9 domain containing 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of B9D1 mRNA CTD PMID:17183730 NCBI chr10:47,784,294...47,794,399
Ensembl chr10:47,785,033...47,792,590
Ensembl chr10:47,785,033...47,792,590
JBrowse link
G Bad BCL2-associated agonist of cell death multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of BAD mRNA CTD PMID:17183730 NCBI chr 1:222,198,516...222,207,459
Ensembl chr 1:222,198,534...222,207,453
JBrowse link
G Bag1 BAG cochaperone 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of BAG1 mRNA CTD PMID:17183730 NCBI chr 5:57,254,421...57,267,002
Ensembl chr 5:57,254,421...57,267,002
JBrowse link
G Bckdk branched chain ketoacid dehydrogenase kinase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of BCKDK mRNA CTD PMID:17183730 NCBI chr 1:199,351,628...199,356,299
Ensembl chr 1:199,351,628...199,356,881
JBrowse link
G Bola1 bolA family member 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of BOLA1 mRNA CTD PMID:17183730 NCBI chr 2:198,338,114...198,339,130
Ensembl chr 2:198,338,114...198,339,130
JBrowse link
G Bpgm bisphosphoglycerate mutase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of BPGM mRNA CTD PMID:17183730 NCBI chr 4:61,912,210...61,940,697
Ensembl chr 4:61,912,210...61,940,696
JBrowse link
G Bpifb2 BPI fold containing family B, member 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of BPIFB2 mRNA CTD PMID:17183730 NCBI chr 3:149,358,881...149,377,867
Ensembl chr 3:149,358,881...149,377,867
JBrowse link
G Bptf bromodomain PHD finger transcription factor multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of BPTF mRNA CTD PMID:17183730 NCBI chr10:95,248,573...95,350,162
Ensembl chr10:95,250,294...95,349,789
JBrowse link
G Brd8 bromodomain containing 8 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of BRD8 mRNA CTD PMID:17183730 NCBI chr18:27,375,645...27,423,989
Ensembl chr18:27,398,688...27,424,090
JBrowse link
G C1qtnf5 C1q and TNF related 5 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of C1QTNF5 mRNA CTD PMID:17183730 NCBI chr 8:48,443,515...48,445,639
Ensembl chr 8:48,443,767...48,445,637
JBrowse link
G C4a complement C4A multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of C4A mRNA CTD PMID:17183730 NCBI chr20:2,651,599...2,678,183
Ensembl chr20:2,651,599...2,678,141
JBrowse link
G Ca8 carbonic anhydrase 8 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of CA8 mRNA CTD PMID:17183730 NCBI chr 5:21,249,018...21,345,810
Ensembl chr 5:21,249,020...21,345,810
JBrowse link
G Cacng6 calcium voltage-gated channel auxiliary subunit gamma 6 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CACNG6 mRNA CTD PMID:17183730 NCBI chr 1:64,307,684...64,322,124
Ensembl chr 1:64,305,438...64,321,241
JBrowse link
G Camlg calcium modulating ligand multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CAMLG mRNA CTD PMID:17183730 NCBI chr17:9,523,792...9,534,683
Ensembl chr17:9,523,795...9,534,653
JBrowse link
G Canx calnexin multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CANX mRNA CTD PMID:17183730 NCBI chr10:35,800,942...35,833,939
Ensembl chr10:35,800,942...35,833,861
JBrowse link
G Car7 carbonic anhydrase 7 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CA7 mRNA CTD PMID:17183730 NCBI chr19:636,545...645,935
Ensembl chr19:636,545...645,937
JBrowse link
G Casd1 CAS1 domain containing 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CASD1 mRNA CTD PMID:17183730 NCBI chr 4:29,638,280...29,693,151
Ensembl chr 4:29,639,154...29,691,928
JBrowse link
G Casp12 caspase 12 multiple interactions ISO Hydralazine inhibits the reaction [Ethanol results in increased cleavage of CASP12 protein] CTD PMID:28119953 NCBI chr 8:2,658,892...2,686,160
Ensembl chr 8:2,659,865...2,686,160
JBrowse link
G Cbx7 chromobox 7 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CBX7 mRNA CTD PMID:17183730 NCBI chr 7:121,136,067...121,153,503
Ensembl chr 7:121,136,058...121,153,383
JBrowse link
G Ccdc138 coiled-coil domain containing 138 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CCDC138 mRNA CTD PMID:17183730 NCBI chr20:28,076,784...28,158,053
Ensembl chr20:28,078,500...28,157,071
JBrowse link
G Ccdc146 coiled-coil domain containing 146 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of CCDC146 mRNA CTD PMID:17183730 NCBI chr 4:10,269,798...10,421,724
Ensembl chr 4:10,295,122...10,421,415
JBrowse link
G Ccdc47 coiled-coil domain containing 47 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CCDC47 mRNA CTD PMID:17183730 NCBI chr10:94,388,425...94,406,949
Ensembl chr10:94,388,430...94,406,949
JBrowse link
G Ccdc82 coiled-coil domain containing 82 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CCDC82 mRNA CTD PMID:17183730 NCBI chr 8:11,888,460...11,927,920
Ensembl chr 8:11,888,591...11,927,919
JBrowse link
G Ccl22 C-C motif chemokine ligand 22 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CCL22 mRNA CTD PMID:17183730 NCBI chr19:10,674,189...10,681,145
Ensembl chr19:10,674,189...10,681,145
JBrowse link
G Ccl28 C-C motif chemokine ligand 28 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CCL28 mRNA CTD PMID:17183730 NCBI chr 2:52,379,341...52,403,979
Ensembl chr 2:52,379,341...52,404,246
JBrowse link
G Ccl4 C-C motif chemokine ligand 4 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CCL4 mRNA CTD PMID:17183730 NCBI chr10:70,870,926...70,886,357
Ensembl chr10:70,884,531...70,886,355
JBrowse link
G Ccm2 CCM2 scaffold protein multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CCM2 mRNA CTD PMID:17183730 NCBI chr14:86,812,728...86,859,408
Ensembl chr14:86,813,082...86,859,406
JBrowse link
G Cct2 chaperonin containing TCP1 subunit 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CCT2 mRNA CTD PMID:17183730 NCBI chr 7:60,106,532...60,122,779
Ensembl chr 7:60,109,974...60,122,805
JBrowse link
G Cct7 chaperonin containing TCP1 subunit 7 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CCT7 mRNA CTD PMID:17183730 NCBI chr 4:117,235,023...117,252,265
Ensembl chr 4:117,235,023...117,252,265
JBrowse link
G Ccz1b CCZ1 homolog B, vacuolar protein trafficking and biogenesis associated multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CCZ1B mRNA CTD PMID:17183730 NCBI chr12:12,638,849...12,662,371
Ensembl chr12:12,638,864...12,662,371
JBrowse link
G Cd63 Cd63 molecule multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CD63 mRNA CTD PMID:17183730 NCBI chr 7:3,320,250...3,335,583
Ensembl chr 7:3,320,103...3,335,582
JBrowse link
G Cdadc1 cytidine and dCMP deaminase domain containing 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CDADC1 mRNA CTD PMID:17183730 NCBI chr15:39,865,094...39,894,122
Ensembl chr15:39,882,210...39,893,979
JBrowse link
G Cdc37 cell division cycle 37, HSP90 cochaperone multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CDC37 mRNA CTD PMID:17183730 NCBI chr 8:22,160,922...22,173,797
Ensembl chr 8:22,154,067...22,173,804
JBrowse link
G Cdc42 cell division cycle 42 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CDC42 mRNA CTD PMID:17183730 NCBI chr 5:155,690,267...155,728,385
Ensembl chr 5:155,691,390...155,728,300
JBrowse link
G Cdk12 cyclin-dependent kinase 12 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CDK12 mRNA CTD PMID:17183730 NCBI chr10:86,157,186...86,210,657
Ensembl chr10:86,157,608...86,222,707
JBrowse link
G Cdk4 cyclin-dependent kinase 4 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CDK4 mRNA CTD PMID:17183730 NCBI chr 7:70,345,971...70,352,689
Ensembl chr 7:70,349,863...70,352,418
JBrowse link
G Cdkn1b cyclin-dependent kinase inhibitor 1B multiple interactions EXP [troglitazone co-treated with [Hydrochlorothiazide co-treated with Hydralazine co-treated with Reserpine]] results in decreased expression of CDKN1B protein CTD PMID:11318962 NCBI chr 4:168,689,043...168,694,159
Ensembl chr 4:168,689,163...168,693,964
JBrowse link
G Cdkn2a cyclin-dependent kinase inhibitor 2A multiple interactions
decreases methylation
EXP
ISO
[Hydrochlorothiazide co-treated with Hydralazine co-treated with Reserpine] inhibits the reaction [Desoxycorticosterone Acetate affects the localization of CDKN2A protein]; [Hydrochlorothiazide co-treated with Hydralazine co-treated with Reserpine] inhibits the reaction [Desoxycorticosterone Acetate results in increased expression of CDKN2A mRNA]
Hydralazine results in decreased methylation of CDKN2A promoter
CTD PMID:15862127, PMID:18504326 NCBI chr 5:107,823,323...107,832,405
Ensembl chr 5:107,823,330...107,841,175
JBrowse link
G Cdr2 cerebellar degeneration-related protein 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CDR2 mRNA CTD PMID:17183730 NCBI chr 1:190,889,698...190,914,606
Ensembl chr 1:190,889,701...190,914,610
JBrowse link
G Cel carboxyl ester lipase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CEL mRNA CTD PMID:17183730 NCBI chr 3:7,134,021...7,141,522
Ensembl chr 3:7,134,021...7,141,522
JBrowse link
G Cenpn centromere protein N multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CENPN mRNA CTD PMID:17183730 NCBI chr19:49,457,461...49,479,989
Ensembl chr19:49,340,184...49,479,996
JBrowse link
G Cers5 ceramide synthase 5 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CERS5 mRNA CTD PMID:17183730 NCBI chr 7:141,386,391...141,424,375
Ensembl chr 7:141,386,391...141,424,343
JBrowse link
G Cfap300 cilia and flagella associated protein 300 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CFAP300 mRNA CTD PMID:17183730 NCBI chr 8:6,218,391...6,236,438
Ensembl chr 8:6,218,393...6,235,967
JBrowse link
G Chchd10 coiled-coil-helix-coiled-coil-helix domain containing 10 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CHCHD10 mRNA CTD PMID:17183730 NCBI chr20:13,665,046...13,666,845
Ensembl chr20:13,665,031...13,667,333
JBrowse link
G Chchd2 coiled-coil-helix-coiled-coil-helix domain containing 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CHCHD2 mRNA CTD PMID:17183730 NCBI chr 9:101,388,148...101,388,819
Ensembl chr 9:101,388,151...101,388,833
JBrowse link
G Chd2 chromodomain helicase DNA binding protein 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CHD2 mRNA CTD PMID:17183730 NCBI chr 1:134,757,934...134,873,053
Ensembl chr 1:134,757,934...134,871,167
JBrowse link
G Chmp5 charged multivesicular body protein 5 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CHMP5 mRNA CTD PMID:17183730 NCBI chr 5:57,267,312...57,284,455
Ensembl chr 5:57,267,312...57,284,448
JBrowse link
G Chn2 chimerin 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CHN2 mRNA CTD PMID:17183730 NCBI chr 4:84,423,708...84,452,989
Ensembl chr 4:84,194,347...84,454,500
JBrowse link
G Chrna1 cholinergic receptor nicotinic alpha 1 subunit multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CHRNA1 mRNA CTD PMID:17183730 NCBI chr 3:60,445,657...60,460,724
Ensembl chr 3:60,445,666...60,460,724
JBrowse link
G Chst13 carbohydrate sulfotransferase 13 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CHST13 mRNA CTD PMID:17183730 NCBI chr 4:122,223,846...122,244,848
Ensembl chr 4:122,224,535...122,237,754
JBrowse link
G Cib1 calcium and integrin binding 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CIB1 mRNA CTD PMID:17183730 NCBI chr 1:142,014,962...142,020,461
Ensembl chr 1:142,014,958...142,020,525
JBrowse link
G Clasp2 cytoplasmic linker associated protein 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CLASP2 mRNA CTD PMID:17183730 NCBI chr 8:122,003,719...122,185,495
Ensembl chr 8:122,003,916...122,185,495
JBrowse link
G Clcn5 chloride voltage-gated channel 5 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CLCN5 mRNA CTD PMID:17183730 NCBI chr  X:16,170,585...16,196,691
Ensembl chr  X:16,050,780...16,196,789
JBrowse link
G Clybl citramalyl-CoA lyase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CLYBL mRNA CTD PMID:17183730 NCBI chr15:108,608,203...108,838,222
Ensembl chr15:108,608,204...108,838,235
JBrowse link
G Cnnm3 cyclin and CBS domain divalent metal cation transport mediator 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CNNM3 mRNA CTD PMID:17183730 NCBI chr 9:43,093,120...43,108,486
Ensembl chr 9:43,093,138...43,108,486
JBrowse link
G Coa3 cytochrome C oxidase assembly factor 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of COA3 mRNA CTD PMID:17183730 NCBI chr10:89,198,750...89,199,731
Ensembl chr10:89,198,749...89,199,736
JBrowse link
G Cog5 component of oligomeric golgi complex 5 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of COG5 mRNA CTD PMID:17183730 NCBI chr 6:50,953,868...51,230,860
Ensembl chr 6:50,954,631...51,230,701
JBrowse link
G Col1a1 collagen type I alpha 1 chain decreases expression
multiple interactions
ISO Hydralazine results in decreased expression of COL1A1 mRNA
[Hydralazine co-treated with Valproic Acid] results in increased expression of COL1A1 mRNA
CTD PMID:8941590, PMID:17183730 NCBI chr10:82,745,801...82,762,790
Ensembl chr10:82,745,801...82,762,789
JBrowse link
G Col4a6 collagen type IV alpha 6 chain multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of COL4A6 mRNA CTD PMID:17183730 NCBI chr  X:112,405,647...112,768,337
Ensembl chr  X:112,405,647...112,473,822
JBrowse link
G Commd1 copper metabolism domain containing 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of COMMD1 mRNA CTD PMID:17183730 NCBI chr14:107,664,321...107,759,974
Ensembl chr14:107,664,255...107,760,191
JBrowse link
G Commd6 COMM domain containing 6 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of COMMD6 mRNA CTD PMID:17183730 NCBI chr15:86,136,096...86,142,672
Ensembl chr15:86,136,096...86,142,672
JBrowse link
G Cope COPI coat complex subunit epsilon multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of COPE mRNA CTD PMID:17183730 NCBI chr16:20,863,141...20,873,516
Ensembl chr16:20,863,141...20,873,521
JBrowse link
G Cops4 COP9 signalosome subunit 4 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of COPS4 mRNA CTD PMID:17183730 NCBI chr14:10,718,863...10,749,134
Ensembl chr14:10,718,844...10,749,120
JBrowse link
G Coq4 coenzyme Q4 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of COQ4 mRNA CTD PMID:17183730 NCBI chr 3:8,349,386...8,357,719
Ensembl chr 3:8,349,185...8,357,871
JBrowse link
G Cox6b1 cytochrome c oxidase subunit 6B1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of COX6B1 mRNA CTD PMID:17183730 NCBI chr 1:89,075,987...89,084,834
Ensembl chr 1:89,075,975...89,084,859
Ensembl chr 2:89,075,975...89,084,859
JBrowse link
G Cox7c cytochrome c oxidase subunit 7C multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of COX7C mRNA CTD PMID:17183730 NCBI chr 2:14,699,878...14,701,903
Ensembl chr 2:14,699,882...14,701,903
JBrowse link
G Cpt1a carnitine palmitoyltransferase 1A multiple interactions EXP Hydralazine inhibits the reaction [AGT protein results in decreased expression of CPT1A mRNA] CTD PMID:19109942 NCBI chr 1:218,568,157...218,629,679
Ensembl chr 1:218,569,510...218,629,678
JBrowse link
G Creb5 cAMP responsive element binding protein 5 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CREB5 mRNA CTD PMID:17183730 NCBI chr 4:83,390,782...83,840,356
Ensembl chr 4:83,391,283...83,836,351
JBrowse link
G Cryba4 crystallin, beta A4 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CRYBA4 mRNA CTD PMID:17183730 NCBI chr12:50,407,843...50,414,434
Ensembl chr12:50,407,843...50,414,432
JBrowse link
G Ctcf CCCTC-binding factor multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of CTCF mRNA CTD PMID:17183730 NCBI chr19:37,600,151...37,649,674
Ensembl chr19:37,600,148...37,649,673
JBrowse link
G Ctnnd1 catenin delta 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CTNND1 mRNA CTD PMID:17183730 NCBI chr 3:72,001,904...72,053,047
Ensembl chr 3:72,002,152...72,053,049
JBrowse link
G Ctsk cathepsin K multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CTSK mRNA CTD PMID:17183730 NCBI chr 2:196,655,469...196,666,447
Ensembl chr 2:196,655,469...196,666,446
JBrowse link
G Cuedc2 CUE domain containing 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CUEDC2 mRNA CTD PMID:17183730 NCBI chr 1:266,078,107...266,087,057
Ensembl chr 1:266,078,108...266,086,299
JBrowse link
G Cul1 cullin 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CUL1 mRNA CTD PMID:17183730 NCBI chr 4:77,211,814...77,283,369
Ensembl chr 4:77,211,692...77,280,250
JBrowse link
G Cyb5r1 cytochrome b5 reductase 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CYB5R1 mRNA CTD PMID:17183730 NCBI chr13:51,229,697...51,236,447
Ensembl chr13:51,229,890...51,236,463
JBrowse link
G Cyb5r3 cytochrome b5 reductase 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CYB5R3 mRNA CTD PMID:17183730 NCBI chr 7:124,024,003...124,041,564
Ensembl chr 7:124,023,995...124,041,594
JBrowse link
G Cyfip2 cytoplasmic FMR1 interacting protein 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CYFIP2 mRNA CTD PMID:17183730 NCBI chr10:31,278,746...31,419,235
Ensembl chr10:31,278,746...31,419,235
JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 multiple interactions EXP
ISO
Hydralazine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein] CTD PMID:18493746 NCBI chr 8:62,472,087...62,478,122
Ensembl chr 8:62,472,095...62,478,147
JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 multiple interactions ISO
EXP
Hydralazine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 NCBI chr 8:62,451,360...62,458,244
Ensembl chr 8:62,451,329...62,458,301
JBrowse link
G Cyp2a3 cytochrome P450, family 2, subfamily a, polypeptide 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CYP2A7 mRNA CTD PMID:17183730 NCBI chr 1:83,653,248...83,662,118
Ensembl chr 1:83,653,234...83,766,484
JBrowse link
G Cyp4x1 cytochrome P450, family 4, subfamily x, polypeptide 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CYP4X1 mRNA CTD PMID:17183730 NCBI chr 5:133,929,532...133,959,447
Ensembl chr 5:133,929,532...133,959,447
JBrowse link
G Dact2 dishevelled-binding antagonist of beta-catenin 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of DACT2 mRNA CTD PMID:17183730 NCBI chr 1:56,159,435...56,169,443
Ensembl chr 1:56,159,426...56,168,351
JBrowse link
G Dancr differentiation antagonizing non-protein coding RNA multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of DANCR mRNA CTD PMID:17183730 NCBI chr14:36,664,036...36,665,016 JBrowse link
G Dapk1 death associated protein kinase 1 decreases methylation
increases expression
ISO Hydralazine results in decreased methylation of DAPK1 promoter
Hydralazine results in increased expression of DAPK1 mRNA
CTD PMID:15862127 NCBI chr17:4,297,038...4,454,941
Ensembl chr17:4,297,224...4,454,778
JBrowse link
G Dbf4b DBF4 zinc finger B multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of DBF4B mRNA CTD PMID:17183730 NCBI chr10:90,710,468...90,723,313 JBrowse link
G Dbi diazepam binding inhibitor, acyl-CoA binding protein multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of DBI mRNA CTD PMID:17183730 NCBI chr13:36,147,667...36,156,076
Ensembl chr13:36,117,119...36,174,908
JBrowse link
G Dcaf8 DDB1 and CUL4 associated factor 8 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of DCAF8 mRNA CTD PMID:17183730 NCBI chr13:90,532,153...90,587,542
Ensembl chr13:90,532,326...90,591,796
JBrowse link
G Dclre1c DNA cross-link repair 1C multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of DCLRE1C mRNA CTD PMID:17183730 NCBI chr17:78,782,512...78,812,140
Ensembl chr17:78,783,437...78,812,111
JBrowse link
G Dcp1a decapping mRNA 1A multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of DCP1A mRNA CTD PMID:17183730 NCBI chr16:6,542,415...6,583,856
Ensembl chr16:6,542,216...6,587,619
JBrowse link
G Ddit3 DNA-damage inducible transcript 3 multiple interactions ISO Hydralazine inhibits the reaction [Ethanol results in increased expression of DDIT3 mRNA]; Hydralazine inhibits the reaction [Ethanol results in increased expression of DDIT3 protein] CTD PMID:28119953 NCBI chr 7:70,578,564...70,585,074
Ensembl chr 7:70,580,198...70,585,084
JBrowse link
G Ddt D-dopachrome tautomerase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of DDT mRNA CTD PMID:17183730 NCBI chr20:13,827,153...13,829,624
Ensembl chr20:13,827,132...13,831,588
JBrowse link
G Ddx27 DEAD-box helicase 27 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of DDX27 mRNA CTD PMID:17183730 NCBI chr 3:163,767,236...163,786,408
Ensembl chr 3:163,767,173...163,786,445
JBrowse link
G Ddx46 DEAD-box helicase 46 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of DDX46 mRNA CTD PMID:17183730 NCBI chr17:9,475,275...9,519,545
Ensembl chr17:9,475,538...9,519,595
JBrowse link
G Dlat dihydrolipoamide S-acetyltransferase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of DLAT mRNA CTD PMID:17183730 NCBI chr 8:55,062,549...55,087,832
Ensembl chr 8:55,062,551...55,087,832
JBrowse link
G Dnaaf5 dynein, axonemal, assembly factor 5 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of DNAAF5 mRNA CTD PMID:17183730 NCBI chr12:17,545,468...17,584,466
Ensembl chr12:17,545,468...17,584,466
JBrowse link
G Dnah14 dynein axonemal heavy chain 14 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of DNAH14 mRNA CTD PMID:17183730 NCBI chr13:99,886,373...100,072,674
NCBI chr13:101,936,210...101,973,640
JBrowse link
G Dnaja3 DnaJ heat shock protein family (Hsp40) member A3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of DNAJA3 mRNA CTD PMID:17183730 NCBI chr10:11,059,701...11,085,186
Ensembl chr10:11,060,313...11,085,210
JBrowse link
G Dnajc3 DnaJ heat shock protein family (Hsp40) member C3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of DNAJC3 mRNA CTD PMID:17183730 NCBI chr15:104,186,918...104,226,236
Ensembl chr15:104,186,792...104,226,329
JBrowse link
G Dnajc8 DnaJ heat shock protein family (Hsp40) member C8 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of DNAJC8 mRNA CTD PMID:17183730 NCBI chr 5:150,725,674...150,743,732
Ensembl chr 5:150,725,654...150,743,730
JBrowse link
G Dnhd1 dynein heavy chain domain 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of DNHD1 mRNA CTD PMID:17183730 NCBI chr 1:170,473,792...170,570,220
Ensembl chr 1:170,471,272...170,565,063
JBrowse link
G Dpy19l3 dpy-19 like C-mannosyltransferase 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of DPY19L3 mRNA CTD PMID:17183730 NCBI chr 1:92,002,927...92,069,855
Ensembl chr 1:92,002,927...92,069,160
JBrowse link
G Drd4 dopamine receptor D4 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of DRD4 mRNA CTD PMID:17183730 NCBI chr 1:214,278,296...214,282,818
Ensembl chr 1:214,278,296...214,281,483
JBrowse link
G Dscc1 DNA replication and sister chromatid cohesion 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of DSCC1 mRNA CTD PMID:17183730 NCBI chr 7:94,759,076...94,774,787
Ensembl chr 7:94,758,800...94,774,569
JBrowse link
G Dync1li1 dynein cytoplasmic 1 light intermediate chain 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of DYNC1LI1 mRNA CTD PMID:17183730 NCBI chr 8:122,743,274...122,776,801
Ensembl chr 8:122,743,189...122,776,806
JBrowse link
G Dynll1 dynein light chain LC8-type 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of DYNLL1 mRNA CTD PMID:17183730 NCBI chr12:47,074,200...47,076,573
Ensembl chr12:47,074,200...47,076,572
JBrowse link
G Edn1 endothelin 1 multiple interactions EXP Hydralazine inhibits the reaction [Nitric Oxide deficiency results in increased expression of EDN1 mRNA] CTD PMID:16326922 NCBI chr17:22,136,814...22,143,745
Ensembl chr17:22,137,324...22,143,324
JBrowse link
G Eef1d eukaryotic translation elongation factor 1 delta multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of EEF1D mRNA CTD PMID:17183730 NCBI chr 7:116,928,264...116,942,981
Ensembl chr 7:116,928,265...116,936,674
JBrowse link
G Efhb EF hand domain family, member B multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of EFHB mRNA CTD PMID:17183730 NCBI chr 9:47,988...120,800
Ensembl chr 9:47,724...120,799
JBrowse link
G Efhd2 EF-hand domain family, member D2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of EFHD2 mRNA CTD PMID:17183730 NCBI chr 5:160,407,777...160,423,811
Ensembl chr 5:160,407,778...160,423,811
JBrowse link
G Ehmt2 euchromatic histone lysine methyltransferase 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of EHMT2 mRNA CTD PMID:17183730 NCBI chr20:4,576,033...4,592,980
Ensembl chr20:4,576,057...4,592,980
JBrowse link
G Eif3l eukaryotic translation initiation factor 3, subunit L multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of EIF3L mRNA CTD PMID:17183730 NCBI chr 7:120,320,547...120,331,596
Ensembl chr 7:120,320,547...120,331,595
JBrowse link
G Eif4b eukaryotic translation initiation factor 4B multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of EIF4B mRNA CTD PMID:17183730 NCBI chr 7:143,679,656...143,701,452
Ensembl chr 7:143,679,617...143,701,452
JBrowse link
G Eif4g3 eukaryotic translation initiation factor 4 gamma, 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of EIF4G3 mRNA CTD PMID:17183730 NCBI chr 5:156,343,663...156,564,037
Ensembl chr 5:156,396,695...156,564,037
JBrowse link
G Elk3 ETS transcription factor ELK3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ELK3 mRNA CTD PMID:17183730 NCBI chr 7:34,086,213...34,149,601
Ensembl chr 7:34,086,220...34,121,694
JBrowse link
G Ell elongation factor for RNA polymerase II multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ELL mRNA CTD PMID:17183730 NCBI chr16:20,594,129...20,641,441
Ensembl chr16:20,594,072...20,641,908
JBrowse link
G Ell3 elongation factor for RNA polymerase II 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of ELL3 mRNA CTD PMID:17183730 NCBI chr 3:113,400,395...113,405,869
Ensembl chr 3:113,401,734...113,405,829
JBrowse link
G Eln elastin multiple interactions EXP [Isoproterenol co-treated with Hydralazine] results in increased expression of ELN protein CTD PMID:3446201 NCBI chr12:24,978,478...25,021,864
Ensembl chr12:24,978,483...25,021,863
JBrowse link
G Elob elongin B multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ELOB mRNA CTD PMID:17183730 NCBI chr10:13,163,032...13,168,217
Ensembl chr10:13,163,036...13,168,217
JBrowse link
G Elovl6 ELOVL fatty acid elongase 6 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ELOVL6 mRNA CTD PMID:17183730 NCBI chr 2:234,187,490...234,296,124
Ensembl chr 2:234,189,105...234,296,145
Ensembl chr 2:234,189,105...234,296,145
JBrowse link
G Emp3 epithelial membrane protein 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of EMP3 mRNA CTD PMID:17183730 NCBI chr 1:101,900,731...101,903,948
Ensembl chr 1:101,900,733...101,903,910
JBrowse link
G Epas1 endothelial PAS domain protein 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of EPAS1 mRNA CTD PMID:17183730 NCBI chr 6:10,306,508...10,385,239
Ensembl chr 6:10,306,405...10,387,265
JBrowse link
G Epc1 enhancer of polycomb homolog 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of EPC1 mRNA CTD PMID:17183730 NCBI chr17:57,303,968...57,394,975
Ensembl chr17:57,304,933...57,394,985
JBrowse link
G Epha8 Eph receptor A8 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of EPHA8 mRNA CTD PMID:17183730 NCBI chr 5:155,293,731...155,321,016
Ensembl chr 5:155,295,314...155,316,495
JBrowse link
G Epn2 epsin 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of EPN2 mRNA CTD PMID:17183730 NCBI chr10:47,795,496...47,857,373
Ensembl chr10:47,795,524...47,857,326
JBrowse link
G Eprs glutamyl-prolyl-tRNA synthetase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of EPRS1 mRNA CTD PMID:17183730 NCBI chr13:103,300,911...103,371,651
Ensembl chr13:103,300,932...103,371,577
JBrowse link
G Erlec1 endoplasmic reticulum lectin 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ERLEC1 mRNA CTD PMID:17183730 NCBI chr14:115,314,890...115,352,871
Ensembl chr14:115,314,890...115,352,562
JBrowse link
G Ero1b endoplasmic reticulum oxidoreductase 1 beta multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ERO1B mRNA CTD PMID:17183730 NCBI chr17:90,709,394...90,783,110
Ensembl chr17:90,710,555...90,756,048
JBrowse link
G Esr1 estrogen receptor 1 decreases methylation
multiple interactions
increases expression
ISO Hydralazine results in decreased methylation of ESR1 promoter
Hydralazine inhibits the reaction [3-methylquinoline results in increased activity of ESR1 protein]; Hydralazine inhibits the reaction [8-methylquinoline results in increased activity of ESR1 protein]
Hydralazine results in increased expression of ESR1 mRNA
CTD PMID:15862127, PMID:30896932 NCBI chr 1:41,192,029...41,594,799
Ensembl chr 1:41,192,824...41,594,796
JBrowse link
G Etl4 enhancer trap locus 4 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of KIAA1217 mRNA CTD PMID:17183730 NCBI chr17:87,173,265...87,681,268
Ensembl chr17:87,274,944...87,681,317
JBrowse link
G Exoc3l2 exocyst complex component 3-like 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of EXOC3L2 mRNA CTD PMID:17183730 NCBI chr 1:80,372,708...80,404,275
Ensembl chr 1:80,383,050...80,404,290
JBrowse link
G Exoc7 exocyst complex component 7 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of EXOC7 mRNA CTD PMID:17183730 NCBI chr10:105,242,152...105,259,795
Ensembl chr10:105,242,152...105,259,795
JBrowse link
G F11r F11 receptor multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of F11R mRNA CTD PMID:17183730 NCBI chr13:89,826,272...89,850,151
Ensembl chr13:89,826,254...89,850,612
JBrowse link
G F12 coagulation factor XII multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of F12 mRNA CTD PMID:17183730 NCBI chr17:9,736,577...9,744,420
Ensembl chr17:9,736,577...9,744,420
JBrowse link
G Fam120a family with sequence similarity 120A multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of FAM120A mRNA CTD PMID:17183730 NCBI chr17:16,106,101...16,196,054
Ensembl chr17:16,106,137...16,194,478
JBrowse link
G Fam13b family with sequence similarity 13, member B multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of FAM13B mRNA CTD PMID:17183730 NCBI chr18:27,223,345...27,304,462
Ensembl chr18:27,223,345...27,289,876
JBrowse link
G Fam155b family with sequence similarity 155, member B multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of TMEM28 mRNA CTD PMID:17183730 NCBI chr  X:69,579,968...69,605,032
Ensembl chr  X:69,580,015...69,605,032
JBrowse link
G Fam156b family with sequence similarity 156, member B multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of TMEM29 mRNA CTD PMID:17183730 NCBI chr  X:20,804,902...20,809,295
Ensembl chr  X:20,806,602...20,807,216
JBrowse link
G Fam162a family with sequence similarity 162, member A multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of FAM162A mRNA CTD PMID:17183730 NCBI chr11:67,618,683...67,646,253
Ensembl chr11:67,618,625...67,646,253
JBrowse link
G Fam163a family with sequence similarity 163, member A multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of FAM163A mRNA CTD PMID:17183730 NCBI chr13:73,741,674...73,820,114
Ensembl chr13:73,741,679...73,819,896
JBrowse link
G Fam210b family with sequence similarity 210, member B multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of FAM210B mRNA CTD PMID:17183730 NCBI chr 3:170,354,109...170,364,265
Ensembl chr 3:170,354,141...170,362,513
JBrowse link
G Fam241b family with sequence similarity 241 member B multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of FAM241B mRNA CTD PMID:17183730 NCBI chr20:31,734,297...31,736,115
Ensembl chr20:31,734,183...31,736,212
JBrowse link
G Fam3a FAM3 metabolism regulating signaling molecule A multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of FAM3A mRNA CTD PMID:17183730 NCBI chr  X:156,319,687...156,328,974
Ensembl chr  X:156,319,687...156,328,309
JBrowse link
G Fam50a family with sequence similarity 50, member A multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of FAM50A mRNA CTD PMID:17183730 NCBI chr  X:156,392,646...156,399,763
Ensembl chr  X:156,392,630...156,399,760
JBrowse link
G Faslg Fas ligand multiple interactions ISO
EXP
Hydralazine inhibits the reaction [Acrolein promotes the reaction [RELA protein binds to FASLG promoter]]; Hydralazine inhibits the reaction [Acrolein promotes the reaction [Zidovudine promotes the reaction [RELA protein binds to FASLG promoter]]]; Hydralazine inhibits the reaction [Acrolein promotes the reaction [Zidovudine results in increased expression of FASLG mRNA]]; Hydralazine inhibits the reaction [Acrolein results in increased expression of FASLG mRNA]; Hydralazine inhibits the reaction [Zidovudine promotes the reaction [Acrolein promotes the reaction [RELA protein binds to FASLG promoter]]]; Hydralazine inhibits the reaction [Zidovudine promotes the reaction [Acrolein results in increased expression of FASLG mRNA]]; Hydralazine inhibits the reaction [Zidovudine promotes the reaction [RELA protein binds to FASLG promoter]]; Hydralazine inhibits the reaction [Zidovudine results in increased expression of FASLG mRNA]
Hydralazine inhibits the reaction [Acrolein promotes the reaction [Zidovudine results in increased expression of FASLG mRNA]]; Hydralazine inhibits the reaction [Acrolein results in increased expression of FASLG mRNA]; Hydralazine inhibits the reaction [Zidovudine promotes the reaction [Acrolein results in increased expression of FASLG mRNA]]; Hydralazine inhibits the reaction [Zidovudine results in increased expression of FASLG mRNA]
CTD PMID:27238871 NCBI chr13:79,696,811...79,717,581
Ensembl chr13:79,698,445...79,705,705
JBrowse link
G Fbrsl1 fibrosin-like 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of FBRSL1 mRNA CTD PMID:17183730 NCBI chr12:52,289,979...52,378,726
Ensembl chr12:52,356,832...52,377,475
JBrowse link
G Fbxw4 F-box and WD repeat domain containing 4 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of FBXW4 mRNA CTD PMID:17183730 NCBI chr 1:265,318,526...265,420,503
Ensembl chr 1:265,318,526...265,420,503
JBrowse link
G Fdps farnesyl diphosphate synthase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of FDPS mRNA CTD PMID:17183730 NCBI chr 2:188,403,595...188,413,219
Ensembl chr 2:188,392,858...188,413,219
JBrowse link
G Ffar3 free fatty acid receptor 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of FFAR3 mRNA CTD PMID:17183730 NCBI chr 1:89,302,035...89,304,064
Ensembl chr 1:89,302,039...89,303,968
JBrowse link
G Fhit fragile histidine triad diadenosine triphosphatase decreases methylation
increases expression
ISO Hydralazine results in decreased methylation of FHIT promoter
Hydralazine results in increased expression of FHIT mRNA
CTD PMID:15862127 NCBI chr15:15,697,292...16,862,873 JBrowse link
G Fis1 fission, mitochondrial 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of FIS1 mRNA CTD PMID:17183730 NCBI chr12:22,750,485...22,765,324
Ensembl chr12:22,750,485...22,765,308
JBrowse link
G Flot1 flotillin 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of FLOT1 mRNA CTD PMID:17183730 NCBI chr20:3,427,890...3,438,418
Ensembl chr20:3,427,880...3,438,396
JBrowse link
G Flt1 Fms related receptor tyrosine kinase 1 multiple interactions EXP [Hydralazine co-treated with Hydrochlorothiazide] inhibits the reaction [Cyclosporine results in increased expression of FLT1 mRNA] CTD PMID:12110003 NCBI chr12:9,033,993...9,205,886
Ensembl chr12:9,034,308...9,205,905
JBrowse link
G Fos Fos proto-oncogene, AP-1 transcription factor subunit affects expression EXP Hydralazine affects the expression of FOS protein CTD PMID:8750937 NCBI chr 6:109,300,433...109,303,299
Ensembl chr 6:109,300,433...109,303,299
JBrowse link
G Foxp1 forkhead box P1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of FOXP1 mRNA CTD PMID:17183730 NCBI chr 4:131,362,178...131,963,466
Ensembl chr 4:131,366,744...131,694,755
JBrowse link
G Foxp2 forkhead box P2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of FOXP2 mRNA CTD PMID:17183730 NCBI chr 4:41,364,441...41,944,685
Ensembl chr 4:41,364,441...41,942,023
JBrowse link
G Foxp3 forkhead box P3 increases expression ISO Hydralazine results in increased expression of FOXP3 protein CTD PMID:19109157 NCBI chr  X:15,753,175...15,768,648
Ensembl chr  X:15,753,175...15,768,522
JBrowse link
G Fst follistatin multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of FST mRNA CTD PMID:17183730 NCBI chr 2:46,537,589...46,544,813
Ensembl chr 2:46,538,700...46,544,457
JBrowse link
G Fstl5 follistatin-like 5 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of FSTL5 mRNA CTD PMID:17183730 NCBI chr 2:174,542,667...175,234,835
Ensembl chr 2:174,542,667...175,233,457
JBrowse link
G Fth1 ferritin heavy chain 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of FTH1 mRNA CTD PMID:17183730 NCBI chr 1:226,030,940...226,033,228
Ensembl chr 1:226,030,938...226,033,228
JBrowse link
G Fthl17e ferritin, heavy polypeptide-like 17, member E multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of FTHL17 mRNA CTD PMID:17183730 NCBI chr  X:53,628,946...53,629,936
Ensembl chr  X:53,629,255...53,629,803
JBrowse link
G Fxyd5 FXYD domain-containing ion transport regulator 5 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of FXYD5 mRNA CTD PMID:17183730 NCBI chr 1:89,464,853...89,474,450
Ensembl chr 1:89,464,860...89,474,252
JBrowse link
G Gabarap GABA type A receptor-associated protein multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of GABARAP mRNA CTD PMID:17183730 NCBI chr10:56,601,288...56,604,223
Ensembl chr10:56,601,288...56,604,221
JBrowse link
G Galnt7 polypeptide N-acetylgalactosaminyltransferase 7 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of GALNT7 mRNA CTD PMID:17183730 NCBI chr16:35,935,059...36,062,734
Ensembl chr16:35,934,970...36,062,719
JBrowse link
G Galp galanin-like peptide multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of GALP mRNA CTD PMID:17183730 NCBI chr 1:71,352,417...71,374,457
Ensembl chr 1:71,352,419...71,373,605
JBrowse link
G Gamt guanidinoacetate N-methyltransferase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of GAMT mRNA CTD PMID:17183730 NCBI chr 7:12,314,848...12,317,998
Ensembl chr 7:12,314,848...12,317,998
JBrowse link
G Ganab glucosidase II alpha subunit multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of GANAB mRNA CTD PMID:17183730 NCBI chr 1:225,096,558...225,116,384
Ensembl chr 1:225,096,598...225,116,378
JBrowse link
G Gatd3a glutamine amidotransferase like class 1 domain containing 3A multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of GATD3A mRNA CTD PMID:17183730 NCBI chr20:11,244,353...11,252,450
Ensembl chr20:11,244,353...11,252,449
JBrowse link
G Gfra2 GDNF family receptor alpha 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of GFRA2 mRNA CTD PMID:17183730 NCBI chr15:52,557,004...52,648,984
Ensembl chr15:52,557,607...52,648,972
JBrowse link
G Gfra3 GDNF family receptor alpha 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of GFRA3 mRNA CTD PMID:17183730 NCBI chr18:27,491,860...27,520,133
Ensembl chr18:27,491,845...27,520,295
JBrowse link
G Gjd4 gap junction protein, delta 4 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of GJD4 mRNA CTD PMID:17183730 NCBI chr17:62,297,086...62,299,655
Ensembl chr17:62,297,086...62,299,655
JBrowse link
G Gla galactosidase, alpha multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of GLA mRNA CTD PMID:17183730 NCBI chr  X:105,405,915...105,417,331
Ensembl chr  X:105,406,792...105,417,323
JBrowse link
G Gnpat glyceronephosphate O-acyltransferase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of GNPAT mRNA CTD PMID:17183730 NCBI chr19:57,614,813...57,640,524
Ensembl chr19:57,614,628...57,640,726
JBrowse link
G Golgb1 golgin B1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of GOLGB1 mRNA CTD PMID:17183730 NCBI chr11:66,761,646...66,819,115
Ensembl chr11:66,761,584...66,819,079
JBrowse link
G Golm2 golgi membrane protein 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of GOLM2 mRNA CTD PMID:17183730 NCBI chr 3:113,818,649...113,887,550
Ensembl chr 3:113,818,872...113,887,495
JBrowse link
G Gp2 glycoprotein 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of GP2 mRNA CTD PMID:17183730 NCBI chr 1:189,166,735...189,182,306
Ensembl chr 1:189,166,399...189,182,306
JBrowse link
G Gpaa1 glycosylphosphatidylinositol anchor attachment 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of GPAA1 mRNA CTD PMID:17183730 NCBI chr 7:117,394,367...117,397,950
Ensembl chr 7:117,394,372...117,397,956
JBrowse link
G Gpbp1l1 GC-rich promoter binding protein 1-like 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of GPBP1L1 mRNA CTD PMID:17183730 NCBI chr 5:135,398,926...135,439,772
Ensembl chr 5:135,412,256...135,439,577
JBrowse link
G Gpr83 G protein-coupled receptor 83 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of GPR83 mRNA CTD PMID:17183730 NCBI chr 8:13,365,583...13,376,071
Ensembl chr 8:13,365,583...13,376,070
JBrowse link
G Gps2 G protein pathway suppressor 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of GPS2 mRNA CTD PMID:17183730 NCBI chr10:56,524,327...56,527,447
Ensembl chr10:56,524,468...56,526,987
JBrowse link
G Gpt glutamic--pyruvic transaminase multiple interactions ISO Hydralazine inhibits the reaction [Ethanol results in increased expression of GPT protein] CTD PMID:28119953 NCBI chr 7:117,759,083...117,761,932
Ensembl chr 7:117,759,083...117,761,931
JBrowse link
G Grap GRB2-related adaptor protein multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of GRAP mRNA CTD PMID:17183730 NCBI chr10:47,930,633...47,949,774
Ensembl chr10:47,930,633...47,949,773
JBrowse link
G Grk3 G protein-coupled receptor kinase 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of GRK3 mRNA CTD PMID:17183730 NCBI chr12:49,626,871...49,750,389
Ensembl chr12:49,626,871...49,746,272
JBrowse link
G Grk4 G protein-coupled receptor kinase 4 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of GRK4 mRNA CTD PMID:17183730 NCBI chr14:81,261,708...81,339,516
Ensembl chr14:81,265,672...81,339,526
JBrowse link
G Grwd1 glutamate-rich WD repeat containing 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of GRWD1 mRNA CTD PMID:17183730 NCBI chr 1:101,813,356...101,819,058
Ensembl chr 1:101,813,684...101,819,478
JBrowse link
G Gsn gelsolin multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of GSN mRNA CTD PMID:17183730 NCBI chr 3:14,456,106...14,508,922
Ensembl chr 3:14,467,330...14,508,911
JBrowse link
G Gstp1 glutathione S-transferase pi 1 decreases methylation
increases expression
ISO Hydralazine results in decreased methylation of GSTP1 promoter
Hydralazine results in increased expression of GSTP1 mRNA
CTD PMID:15862127 NCBI chr 1:219,291,679...219,294,147
Ensembl chr 1:219,291,679...219,294,147
JBrowse link
G Gstt2 glutathione S-transferase, theta 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of GSTT2 mRNA CTD PMID:17183730 NCBI chr20:13,760,810...13,764,481
Ensembl chr20:13,760,810...13,764,475
JBrowse link
G Guk1 guanylate kinase 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of GUK1 mRNA CTD PMID:17183730 NCBI chr10:45,535,617...45,552,455
Ensembl chr10:45,535,627...45,543,897
JBrowse link
G H3f3a H3.3 histone A multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of H3-3A mRNA CTD PMID:17183730 NCBI chr13:99,091,246...99,102,828
Ensembl chr13:99,091,763...99,101,208
JBrowse link
G Haao 3-hydroxyanthranilate 3,4-dioxygenase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of HAAO mRNA CTD PMID:17183730 NCBI chr 6:7,045,145...7,059,227
Ensembl chr 6:7,045,152...7,058,314
JBrowse link
G Hba-a2 hemoglobin alpha, adult chain 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of HBA1 mRNA CTD PMID:17183730 NCBI chr10:15,589,364...15,590,207
Ensembl chr10:15,589,364...15,590,220
JBrowse link
G Hbb hemoglobin subunit beta multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of HBB mRNA CTD PMID:17183730 NCBI chr 1:168,971,269...168,972,680
Ensembl chr 1:168,971,274...168,972,725
JBrowse link
G Hbz hemoglobin subunit zeta multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of HBZ mRNA CTD PMID:17183730 NCBI chr10:15,609,348...15,610,826
Ensembl chr10:15,609,358...15,610,826
JBrowse link
G Hcfc1r1 host cell factor C1 regulator 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of HCFC1R1 mRNA CTD PMID:17183730 NCBI chr10:12,994,229...12,995,674
Ensembl chr10:12,994,683...12,995,457
JBrowse link
G Hdgfl1 HDGF like 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of HDGFL1 mRNA CTD PMID:17183730 NCBI chr17:40,170,522...40,172,518
Ensembl chr17:40,170,541...40,172,426
JBrowse link
G Heatr5b HEAT repeat containing 5B multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of HEATR5B mRNA CTD PMID:17183730 NCBI chr 6:1,330,314...1,410,339
Ensembl chr 6:1,330,314...1,410,339
JBrowse link
G Hebp1 heme binding protein 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of HEBP1 mRNA CTD PMID:17183730 NCBI chr 4:168,903,586...168,933,102
Ensembl chr 4:168,903,565...168,933,079
JBrowse link
G Henmt1 HEN methyltransferase 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of HENMT1 mRNA CTD PMID:17183730 NCBI chr 2:211,740,571...211,753,718 JBrowse link
G Hfe homeostatic iron regulator multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of HFE mRNA CTD PMID:17183730 NCBI chr17:43,661,276...43,669,327
Ensembl chr17:43,661,222...43,669,985
JBrowse link
G Higd2a HIG1 hypoxia inducible domain family, member 2A multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of HIGD2A mRNA CTD PMID:17183730 NCBI chr17:10,558,714...10,559,638
Ensembl chr17:10,558,714...10,559,627
JBrowse link
G Hinfp histone H4 transcription factor multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of HINFP mRNA CTD PMID:17183730 NCBI chr 8:48,626,398...48,638,012
Ensembl chr 8:48,628,340...48,634,797
JBrowse link
G Hint1 histidine triad nucleotide binding protein 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of HINT1 mRNA CTD PMID:17183730 NCBI chr10:40,208,236...40,211,981
Ensembl chr10:40,208,223...40,211,975
JBrowse link
G Hint2 histidine triad nucleotide binding protein 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of HINT2 mRNA CTD PMID:17183730 NCBI chr 5:59,150,344...59,152,599
Ensembl chr 5:59,150,345...59,152,599
JBrowse link
G Hk1 hexokinase 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of HK1 mRNA CTD PMID:17183730 NCBI chr20:31,911,460...31,979,780
Ensembl chr20:31,912,262...31,956,649
JBrowse link
G Hmgcl 3-hydroxy-3-methylglutaryl-CoA lyase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of HMGCL mRNA CTD PMID:17183730 NCBI chr 5:154,294,841...154,308,582
Ensembl chr 5:154,294,806...154,308,640
JBrowse link
G Hmgxb4 HMG-box containing 4 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of HMGXB4 mRNA CTD PMID:17183730 NCBI chr19:14,352,644...14,390,499
Ensembl chr19:14,352,411...14,390,478
JBrowse link
G Hmox1 heme oxygenase 1 multiple interactions ISO Hydralazine inhibits the reaction [[Acrolein binds to ALB protein] which results in increased expression of HMOX1 mRNA] CTD PMID:32530271 NCBI chr19:14,508,634...14,515,455
Ensembl chr19:14,508,616...14,515,456
JBrowse link
G Hps3 HPS3, biogenesis of lysosomal organelles complex 2 subunit 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of HPS3 mRNA CTD PMID:17183730 NCBI chr 2:104,789,423...104,832,964
Ensembl chr 2:104,789,423...104,830,898
JBrowse link
G Hpse heparanase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of HPSE mRNA CTD PMID:17183730 NCBI chr14:10,534,358...10,576,686
Ensembl chr14:10,534,423...10,575,224
JBrowse link
G Hsbp1 heat shock factor binding protein 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of HSBP1 mRNA CTD PMID:17183730 NCBI chr19:51,985,196...51,989,528
Ensembl chr19:51,985,170...51,989,544
JBrowse link
G Hspa5 heat shock protein family A (Hsp70) member 5 multiple interactions ISO Hydralazine inhibits the reaction [Ethanol results in increased expression of HSPA5 mRNA] CTD PMID:28119953 NCBI chr 3:13,838,304...13,842,763
Ensembl chr 3:13,838,304...13,842,762
JBrowse link
G Hspa8 heat shock protein family A (Hsp70) member 8 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of HSPA8 mRNA CTD PMID:17183730 NCBI chr 8:44,989,401...44,993,261
Ensembl chr 8:44,990,014...44,993,179
JBrowse link
G Hyi hydroxypyruvate isomerase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of HYI mRNA CTD PMID:17183730 NCBI chr 5:137,189,440...137,192,125
Ensembl chr 5:137,189,473...137,192,240
JBrowse link
G Icam1 intercellular adhesion molecule 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ICAM1 mRNA CTD PMID:17183730 NCBI chr 8:22,035,287...22,047,049
Ensembl chr 8:22,035,256...22,047,059
JBrowse link
G Icmt isoprenylcysteine carboxyl methyltransferase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ICMT mRNA CTD PMID:17183730 NCBI chr 5:169,475,270...169,482,031
Ensembl chr 5:169,475,270...169,482,030
JBrowse link
G Idh3g isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit gamma multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of IDH3G mRNA CTD PMID:17183730 NCBI chr  X:156,999,803...157,008,735
Ensembl chr  X:156,999,826...157,008,733
JBrowse link
G Ifitm2 interferon induced transmembrane protein 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of IFITM2 mRNA CTD PMID:17183730 NCBI chr 1:213,750,219...213,751,399
Ensembl chr 1:213,750,192...213,751,405
JBrowse link
G Ifrd1 interferon-related developmental regulator 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of IFRD1 mRNA CTD PMID:17183730 NCBI chr 6:60,132,025...60,151,354
Ensembl chr 6:60,132,024...60,151,420
JBrowse link
G Ift22 intraflagellar transport 22 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of IFT22 mRNA CTD PMID:17183730 NCBI chr12:22,804,384...22,811,036
Ensembl chr12:22,803,855...22,811,058
JBrowse link
G Ift57 intraflagellar transport 57 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of IFT57 mRNA CTD PMID:17183730 NCBI chr11:53,664,638...53,731,779
Ensembl chr11:53,664,638...53,731,779
JBrowse link
G Igbp1 immunoglobulin binding protein 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of IGBP1 mRNA CTD PMID:17183730 NCBI chr  X:70,322,764...70,345,005
Ensembl chr  X:70,322,755...70,345,005
JBrowse link
G Igf2bp2 insulin-like growth factor 2 mRNA binding protein 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of IGF2BP2 mRNA CTD PMID:17183730 NCBI chr11:82,466,071...82,621,105
Ensembl chr11:82,466,071...82,621,079
JBrowse link
G Il10 interleukin 10 increases secretion ISO Hydralazine results in increased secretion of IL10 protein CTD PMID:16612254 NCBI chr13:47,738,933...47,743,392
Ensembl chr13:47,739,526...47,743,392
JBrowse link
G Il1rapl2 interleukin 1 receptor accessory protein-like 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of IL1RAPL2 mRNA CTD PMID:17183730 NCBI chr  X:108,287,034...109,851,075
Ensembl chr  X:108,287,068...109,851,047
JBrowse link
G Il3 interleukin 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of IL3 mRNA CTD PMID:17183730 NCBI chr10:39,620,535...39,622,973
Ensembl chr10:39,620,563...39,622,973
JBrowse link
G Il6 interleukin 6 decreases secretion
increases expression
ISO Hydralazine results in decreased secretion of IL6 protein
Hydralazine results in increased expression of IL6 protein
CTD PMID:16612254, PMID:19575532 NCBI chr 4:3,043,231...3,047,807
Ensembl chr 4:3,043,231...3,047,807
JBrowse link
G Inava innate immunity activator multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of INAVA mRNA CTD PMID:17183730 NCBI chr13:53,088,438...53,108,713
Ensembl chr13:53,088,439...53,108,713
JBrowse link
G Ino80e INO80 complex subunit E multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of INO80E mRNA CTD PMID:17183730 NCBI chr 1:198,287,489...198,298,076
Ensembl chr 1:198,287,490...198,298,076
JBrowse link
G Irf7 interferon regulatory factor 7 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of IRF7 mRNA CTD PMID:17183730 NCBI chr 1:214,249,388...214,252,909
Ensembl chr 1:214,248,837...214,252,456
JBrowse link
G Irx3 iroquois homeobox 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of IRX3 mRNA CTD PMID:17183730 NCBI chr19:15,838,714...15,842,135
Ensembl chr19:15,838,714...15,840,990
JBrowse link
G Isca2 iron-sulfur cluster assembly 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ISCA2 mRNA CTD PMID:17183730 NCBI chr 6:108,488,678...108,490,188
Ensembl chr 6:108,488,678...108,490,188
JBrowse link
G Itgam integrin subunit alpha M multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of ITGAM mRNA CTD PMID:17183730 NCBI chr 1:199,495,312...199,545,738
Ensembl chr 1:199,495,298...199,623,960
JBrowse link
G Itsn1 intersectin 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ITSN1 mRNA CTD PMID:17183730 NCBI chr11:31,943,119...32,069,249
Ensembl chr11:31,893,489...32,069,249
JBrowse link
G Itsn2 intersectin 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ITSN2 mRNA CTD PMID:17183730 NCBI chr 6:30,098,378...30,208,694
Ensembl chr 6:30,098,380...30,187,337
JBrowse link
G Jarid2 jumonji and AT-rich interaction domain containing 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of JARID2 mRNA CTD PMID:17183730 NCBI chr17:20,183,440...20,365,219
Ensembl chr17:20,184,245...20,364,714
JBrowse link
G Jmjd1c jumonji domain containing 1C multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of JMJD1C mRNA CTD PMID:17183730 NCBI chr20:22,751,743...22,914,080
Ensembl chr20:22,751,743...22,882,672
JBrowse link
G Kank1 KN motif and ankyrin repeat domains 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of KANK1 mRNA CTD PMID:17183730 NCBI chr 1:243,201,073...243,398,531
Ensembl chr 1:243,276,403...243,398,536
JBrowse link
G Kank4 KN motif and ankyrin repeat domains 4 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of KANK4 mRNA CTD PMID:17183730 NCBI chr 5:117,376,425...117,440,643
Ensembl chr 5:117,376,423...117,440,254
JBrowse link
G Kcna7 potassium voltage-gated channel subfamily A member 7 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of KCNA7 mRNA CTD PMID:17183730 NCBI chr 1:101,397,828...101,403,320
Ensembl chr 1:101,397,828...101,403,320
JBrowse link
G Kdelr3 KDEL endoplasmic reticulum protein retention receptor 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of KDELR3 mRNA CTD PMID:17183730 NCBI chr 7:120,749,680...120,760,163
Ensembl chr 7:120,749,752...120,760,160
JBrowse link
G Klf6 Kruppel-like factor 6 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of KLF6 mRNA CTD PMID:17183730 NCBI chr17:67,887,939...67,945,052
Ensembl chr17:67,887,939...67,945,037
JBrowse link
G Klhl9 kelch-like family member 9 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of KLHL9 mRNA CTD PMID:17183730 NCBI chr 5:107,323,258...107,327,442
Ensembl chr 5:107,323,258...107,327,442
JBrowse link
G Krt17 keratin 17 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of KRT17 mRNA CTD PMID:17183730 NCBI chr10:88,158,993...88,163,712
Ensembl chr10:88,118,001...88,163,723
JBrowse link
G Lasp1 LIM and SH3 protein 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of LASP1 mRNA CTD PMID:17183730 NCBI chr10:85,744,662...85,785,130
Ensembl chr10:85,744,568...85,785,133
JBrowse link
G Lef1 lymphoid enhancer binding factor 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of LEF1 mRNA CTD PMID:17183730 NCBI chr 2:236,232,115...236,345,061
Ensembl chr 2:236,233,239...236,345,056
JBrowse link
G Lgals1 galectin 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of LGALS1 mRNA CTD PMID:17183730 NCBI chr 7:120,153,184...120,156,290
Ensembl chr 7:120,153,184...120,156,289
JBrowse link
G Lgals2 galectin 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of LGALS2 mRNA CTD PMID:17183730 NCBI chr 7:120,071,122...120,077,612
Ensembl chr 7:120,071,124...120,077,612
JBrowse link
G Lgr4 leucine-rich repeat-containing G protein-coupled receptor 4 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of LGR4 mRNA CTD PMID:17183730 NCBI chr 3:101,051,960...101,152,119
Ensembl chr 3:101,051,955...101,152,119
JBrowse link
G Lhfpl5 LHFPL tetraspan subfamily member 5 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of LHFPL5 mRNA CTD PMID:17183730 NCBI chr20:5,815,837...5,826,137
Ensembl chr20:5,815,837...5,826,137
JBrowse link
G Lin37 lin-37 DREAM MuvB core complex component multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of LIN37 mRNA CTD PMID:17183730 NCBI chr 1:89,010,254...89,014,481
Ensembl chr 1:89,010,257...89,014,189
JBrowse link
G LOC100364500 RT1 class I, locus CE11-like multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of HLA-A mRNA CTD PMID:17183730 NCBI chr20:2,704,153...2,707,111
Ensembl chr20:2,704,148...2,707,120
JBrowse link
G LOC102548695 zinc finger protein 45-like multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ZNF45 mRNA CTD PMID:17183730 NCBI chr 1:81,158,743...81,173,245
Ensembl chr 1:81,159,107...81,163,689
JBrowse link
G LOC498675 hypothetical LOC498675 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of C3ORF62 mRNA CTD PMID:17183730 NCBI chr 8:117,170,620...117,175,235
Ensembl chr 8:117,170,620...117,175,235
JBrowse link
G LOC685849 hypothetical protein LOC685849 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of C9ORF152 mRNA CTD PMID:17183730 NCBI chr 5:74,997,426...75,005,688
Ensembl chr 5:74,997,843...75,005,567
JBrowse link
G LOC686596 similar to aquaporin 10 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of AQP10 mRNA CTD PMID:17183730 NCBI chr 2:189,309,151...189,314,092 JBrowse link
G LOC690035 similar to Protein KIAA0586 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of KIAA0586 mRNA CTD PMID:17183730 NCBI chr 6:93,562,775...93,667,857
Ensembl chr 6:93,563,446...93,667,675
JBrowse link
G Lpcat4 lysophosphatidylcholine acyltransferase 4 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of LPCAT4 mRNA CTD PMID:17183730 NCBI chr 3:103,725,762...103,733,888
Ensembl chr 3:103,726,238...103,733,354
JBrowse link
G Lpgat1 lysophosphatidylglycerol acyltransferase 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of LPGAT1 mRNA CTD PMID:17183730 NCBI chr13:110,397,353...110,470,874
Ensembl chr13:110,398,800...110,467,834
JBrowse link
G Lpin3 lipin 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of LPIN3 mRNA CTD PMID:17183730 NCBI chr 3:156,874,805...156,899,601
Ensembl chr 3:156,886,454...156,899,436
JBrowse link
G Lpp LIM domain containing preferred translocation partner in lipoma multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of LPP mRNA CTD PMID:17183730 NCBI chr11:79,192,603...79,827,858
Ensembl chr11:79,205,730...79,703,736
JBrowse link
G Lrfn1 leucine rich repeat and fibronectin type III domain containing 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of LRFN1 mRNA CTD PMID:17183730 NCBI chr 1:85,290,887...85,308,498
Ensembl chr 1:85,291,462...85,300,825
JBrowse link
G Lrp10 LDL receptor related protein 10 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of LRP10 mRNA CTD PMID:17183730 NCBI chr15:33,107,706...33,114,831
Ensembl chr15:33,108,671...33,114,829
JBrowse link
G Lrrc40 leucine rich repeat containing 40 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of LRRC40 mRNA CTD PMID:17183730 NCBI chr 2:264,864,321...264,894,588
Ensembl chr 2:264,864,351...264,893,294
JBrowse link
G Lrrc8e leucine rich repeat containing 8 VRAC subunit E multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of LRRC8E mRNA CTD PMID:17183730 NCBI chr12:2,557,267...2,568,416
Ensembl chr12:2,557,275...2,568,382
JBrowse link
G Luc7l3 LUC7-like 3 pre-mRNA splicing factor multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of CROP mRNA CTD PMID:17183730 NCBI chr10:81,991,147...82,027,119
Ensembl chr10:81,991,147...82,027,119
JBrowse link
G Ly86 lymphocyte antigen 86 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of LY86 mRNA CTD PMID:17183730 NCBI chr17:28,104,535...28,191,447
Ensembl chr17:28,104,589...28,191,436
JBrowse link
G Maoa monoamine oxidase A multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MAOA mRNA CTD PMID:17183730 NCBI chr  X:6,554,698...6,620,722
Ensembl chr  X:6,554,698...6,620,722
JBrowse link
G Map2k3 mitogen activated protein kinase kinase 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MAP2K3 mRNA CTD PMID:17183730 NCBI chr10:45,089,455...45,110,802
Ensembl chr10:47,182,433...47,203,753
JBrowse link
G Mapk1 mitogen activated protein kinase 1 multiple interactions EXP Hydralazine inhibits the reaction [AGT protein modified form results in increased phosphorylation of MAPK1 protein] CTD PMID:16344371 NCBI chr11:88,203,863...88,273,301
Ensembl chr11:88,211,599...88,273,254
JBrowse link
G Mapk3 mitogen activated protein kinase 3 multiple interactions EXP Hydralazine inhibits the reaction [AGT protein modified form results in increased phosphorylation of MAPK3 protein] CTD PMID:16344371 NCBI chr 1:198,192,773...198,198,975
Ensembl chr 1:198,192,773...198,198,975
JBrowse link
G Mark3 microtubule affinity regulating kinase 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MARK3 mRNA CTD PMID:17183730 NCBI chr 6:136,040,957...136,129,780
Ensembl chr 6:136,041,777...136,129,661
JBrowse link
G Mas1 MAS1 proto-oncogene, G protein-coupled receptor multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MAS1 mRNA CTD PMID:17183730 NCBI chr 1:48,076,761...48,108,218
Ensembl chr 1:48,077,033...48,108,216
JBrowse link
G Mbd6 methyl-CpG binding domain protein 6 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MBD6 mRNA CTD PMID:17183730 NCBI chr 7:70,571,435...70,580,146
Ensembl chr 7:70,571,435...70,577,147
JBrowse link
G Mboat7 membrane bound O-acyltransferase domain containing 7 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MBOAT7 mRNA CTD PMID:17183730 NCBI chr 1:64,100,159...64,114,437
Ensembl chr 1:64,101,018...64,113,792
JBrowse link
G Me2 malic enzyme 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ME2 mRNA CTD PMID:17183730 NCBI chr18:69,737,515...69,784,099
Ensembl chr18:69,738,686...69,784,099
JBrowse link
G Mettl3 methyltransferase-like 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of METTL3 mRNA CTD PMID:17183730 NCBI chr15:28,710,299...28,721,491
Ensembl chr15:28,710,300...28,721,127
JBrowse link
G Mettl6 methyltransferase like 6 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of METTL6 mRNA CTD PMID:17183730 NCBI chr16:7,559,964...7,588,841
Ensembl chr16:7,573,750...7,588,841
JBrowse link
G Mfsd5 major facilitator superfamily domain containing 5 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MFSD5 mRNA CTD PMID:17183730 NCBI chr 7:143,882,000...143,884,281
Ensembl chr 7:143,882,000...143,884,280
JBrowse link
G Mgat1 alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MGAT1 mRNA CTD PMID:17183730 NCBI chr10:34,518,392...34,537,214
Ensembl chr10:34,519,790...34,537,210
JBrowse link
G Mgmt O-6-methylguanine-DNA methyltransferase decreases methylation
increases expression
ISO Hydralazine results in decreased methylation of MGMT promoter
Hydralazine results in increased expression of MGMT mRNA
CTD PMID:15862127 NCBI chr 1:209,237,255...209,464,189
Ensembl chr 1:209,237,233...209,464,190
JBrowse link
G Mgp matrix Gla protein multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MGP mRNA CTD PMID:17183730 NCBI chr 4:170,856,783...170,860,105
Ensembl chr 4:170,856,751...170,860,225
JBrowse link
G Mical3 microtubule associated monooxygenase, calponin and LIM domain containing 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MICAL3 mRNA CTD PMID:17183730 NCBI chr 4:153,484,876...153,631,986
Ensembl chr 4:153,484,876...153,593,773
JBrowse link
G Micos13 mitochondrial contact site and cristae organizing system subunit 13 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MICOS13 mRNA CTD PMID:17183730 NCBI chr 9:10,446,567...10,449,566
Ensembl chr 9:10,446,699...10,449,566
JBrowse link
G Mis12 MIS12 kinetochore complex component multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MIS12 mRNA CTD PMID:17183730 NCBI chr10:57,653,685...57,661,833
Ensembl chr10:57,660,067...57,660,687
JBrowse link
G Mks1 MKS transition zone complex subunit 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MKS1 mRNA CTD PMID:17183730 NCBI chr10:75,149,814...75,160,481
Ensembl chr10:75,149,814...75,160,480
JBrowse link
G Mllt10 MLLT10, histone lysine methyltransferase DOT1L cofactor multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MLLT10 mRNA CTD PMID:17183730 NCBI chr17:84,847,660...84,981,134
Ensembl chr17:84,881,414...84,979,543
JBrowse link
G Mmab metabolism of cobalamin associated B multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MMAB mRNA CTD PMID:17183730 NCBI chr12:47,920,712...47,935,438
Ensembl chr12:47,920,743...47,935,525
JBrowse link
G Mme membrane metallo-endopeptidase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MME mRNA CTD PMID:17183730 NCBI chr 2:153,799,203...153,880,910
Ensembl chr 2:153,803,349...153,880,738
JBrowse link
G Mmp10 matrix metallopeptidase 10 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MMP10 mRNA CTD PMID:17183730 NCBI chr 8:5,734,348...5,742,243
Ensembl chr 8:5,734,348...5,742,243
JBrowse link
G Mmp25 matrix metallopeptidase 25 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MMP25 mRNA CTD PMID:17183730 NCBI chr10:12,962,214...12,966,377 JBrowse link
G Mpst mercaptopyruvate sulfurtransferase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MPST mRNA CTD PMID:17183730 NCBI chr 7:119,626,636...119,631,317
Ensembl chr 7:119,626,637...119,631,425
JBrowse link
G Mrnip MRN complex interacting protein multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MRNIP mRNA CTD PMID:17183730 NCBI chr10:35,680,687...35,704,685
Ensembl chr10:35,680,658...35,704,776
JBrowse link
G mrpl11 mitochondrial ribosomal protein L11 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MRPL11 mRNA CTD PMID:17183730 NCBI chr 1:220,243,469...220,246,340
Ensembl chr 1:220,243,473...220,246,346
JBrowse link
G Mrpl39 mitochondrial ribosomal protein L39 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MRPL39 mRNA CTD PMID:17183730 NCBI chr11:24,181,605...24,200,022
Ensembl chr11:24,181,658...24,199,968
JBrowse link
G Mrpl45 mitochondrial ribosomal protein L45 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MRPL45 mRNA CTD PMID:17183730 NCBI chr10:85,257,876...85,269,806
Ensembl chr10:85,257,876...85,269,806
JBrowse link
G Mrpl53 mitochondrial ribosomal protein L53 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MRPL53 mRNA CTD PMID:17183730 NCBI chr 4:113,942,037...113,942,927
Ensembl chr 4:113,942,041...113,942,674
JBrowse link
G Mrps12 mitochondrial ribosomal protein S12 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MRPS12 mRNA CTD PMID:17183730 NCBI chr 1:86,920,679...86,923,626
Ensembl chr 1:86,920,680...86,923,575
JBrowse link
G Mrps18a mitochondrial ribosomal protein S18A multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MRPS18A mRNA CTD PMID:17183730 NCBI chr 9:17,238,354...17,254,845
Ensembl chr 9:17,238,385...17,254,949
JBrowse link
G Mrps24 mitochondrial ribosomal protein S24 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MRPS24 mRNA CTD PMID:17183730 NCBI chr14:85,947,763...85,951,891
Ensembl chr14:85,947,765...85,951,899
JBrowse link
G Mrps5 mitochondrial ribosomal protein S5 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MRPS5 mRNA CTD PMID:17183730 NCBI chr 3:120,165,953...120,182,536
Ensembl chr 3:120,165,913...120,182,536
JBrowse link
G Mrrf mitochondrial ribosome recycling factor multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MRRF mRNA CTD PMID:17183730 NCBI chr 3:15,463,884...15,520,621
Ensembl chr 3:15,463,953...15,520,618
JBrowse link
G Mta3 metastasis associated 1 family, member 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MTA3 mRNA CTD PMID:17183730 NCBI chr 6:6,904,449...7,036,929
Ensembl chr 6:6,908,684...7,031,828
JBrowse link
G Mtmr4 myotubularin related protein 4 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MTMR4 mRNA CTD PMID:17183730 NCBI chr10:74,886,600...74,909,532
Ensembl chr10:74,886,985...74,909,533
JBrowse link
G Muc1 mucin 1, cell surface associated multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MUC1 mRNA CTD PMID:17183730 NCBI chr 2:188,543,137...188,547,874
Ensembl chr 2:188,543,137...188,547,874
JBrowse link
G Mybl2 MYB proto-oncogene like 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MYBL2 mRNA CTD PMID:17183730 NCBI chr 3:159,421,638...159,450,087
Ensembl chr 3:159,421,671...159,450,086
JBrowse link
G Mycbp2 MYC binding protein 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MYCBP2 mRNA CTD PMID:17183730 NCBI chr15:87,405,472...87,450,812
NCBI chr15:93,678,062...93,901,556
Ensembl chr15:87,506,959...93,868,301
JBrowse link
G Myh7 myosin heavy chain 7 multiple interactions EXP Hydralazine inhibits the reaction [Nitric Oxide deficiency results in increased expression of MYH7 mRNA] CTD PMID:16326922 NCBI chr15:33,605,769...33,657,761
Ensembl chr15:33,634,422...33,656,089
JBrowse link
G Myl6b myosin light chain 6B multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MYL6B mRNA CTD PMID:17183730 NCBI chr  X:43,831,778...43,833,044 JBrowse link
G Myom1 myomesin 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MYOM1 mRNA CTD PMID:17183730 NCBI chr 9:119,353,840...119,469,196
Ensembl chr 9:119,353,840...119,468,715
JBrowse link
G Myot myotilin multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of MYOT mRNA CTD PMID:17183730 NCBI chr18:35,573,978...35,593,541
Ensembl chr18:35,574,002...35,593,541
JBrowse link
G Naa10 N(alpha)-acetyltransferase 10, NatA catalytic subunit multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NAA10 mRNA CTD PMID:17183730 NCBI chr  X:156,863,655...156,868,950
Ensembl chr  X:156,863,754...156,868,950
JBrowse link
G Naa38 N(alpha)-acetyltransferase 38, NatC auxiliary subunit multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NAA38 mRNA CTD PMID:17183730 NCBI chr10:55,997,614...55,998,691
Ensembl chr10:55,997,614...55,998,691
JBrowse link
G Nalcn sodium leak channel, non-selective multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NALCN mRNA CTD PMID:17183730 NCBI chr15:109,734,092...110,046,729
Ensembl chr15:109,735,595...110,046,704
JBrowse link
G Nampt nicotinamide phosphoribosyltransferase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of NAMPT mRNA CTD PMID:17183730 NCBI chr 6:52,122,085...52,156,473
Ensembl chr 6:52,122,085...52,156,472
JBrowse link
G Nap1l1 nucleosome assembly protein 1-like 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NAP1L1 mRNA CTD PMID:17183730 NCBI chr 7:54,213,305...54,237,880
Ensembl chr 7:54,213,319...54,236,625
JBrowse link
G Nat2 N-acetyltransferase 2 increases acetylation
affects metabolic processing
ISO NAT2 protein results in increased acetylation of Hydralazine
NAT2 protein affects the metabolism of Hydralazine
CTD PMID:15627487 NCBI chr16:23,960,709...23,991,570
Ensembl chr16:23,961,067...23,991,570
JBrowse link
G Nbeal1 neurobeachin-like 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NBEAL1 mRNA CTD PMID:17183730 NCBI chr 9:66,951,354...67,113,395
Ensembl chr 9:66,952,720...67,110,693
JBrowse link
G Nbr1 NBR1, autophagy cargo receptor multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of NBR1 mRNA CTD PMID:17183730 NCBI chr10:89,455,202...89,483,791
Ensembl chr10:89,459,650...89,484,080
JBrowse link
G Ncf1 neutrophil cytosolic factor 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NCF1 mRNA CTD PMID:17183730 NCBI chr12:25,497,104...25,506,300
Ensembl chr12:25,497,104...25,506,300
JBrowse link
G Ncoa4 nuclear receptor coactivator 4 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NCOA4 mRNA CTD PMID:17183730 NCBI chr16:8,302,950...8,323,294
Ensembl chr16:8,302,950...8,323,293
JBrowse link
G Ncor1 nuclear receptor co-repressor 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NCOR1 mRNA CTD PMID:17183730 NCBI chr10:48,629,121...48,772,890
Ensembl chr10:48,629,121...48,772,890
JBrowse link
G Ncr1 natural cytotoxicity triggering receptor 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of NCR1 mRNA CTD PMID:17183730 NCBI chr 1:73,178,917...73,226,504
Ensembl chr 1:73,179,013...73,226,777
JBrowse link
G Ndufa1 NADH:ubiquinone oxidoreductase subunit A1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NDUFA1 mRNA CTD PMID:17183730 NCBI chr  X:123,803,109...123,806,760
Ensembl chr  X:124,513,269...124,516,705
Ensembl chr  X:124,513,269...124,516,705
JBrowse link
G Ndufa13 NADH:ubiquinone oxidoreductase subunit A13 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NDUFA13 mRNA CTD PMID:17183730 NCBI chr16:21,275,311...21,282,246
Ensembl chr16:21,275,311...21,282,246
JBrowse link
G Ndufa3 NADH:ubiquinone oxidoreductase subunit A3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NDUFA3 mRNA CTD PMID:17183730 NCBI chr 1:64,172,462...64,175,174
Ensembl chr 1:64,172,540...64,175,099
JBrowse link
G Ndufa5 NADH:ubiquinone oxidoreductase subunit A5 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NDUFA5 mRNA CTD PMID:17183730 NCBI chr 4:51,590,413...51,598,771
Ensembl chr 4:51,590,413...51,598,771
JBrowse link
G Ndufa6 NADH:ubiquinone oxidoreductase subunit A6 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NDUFA6 mRNA CTD PMID:17183730 NCBI chr 7:123,583,062...123,586,919
Ensembl chr 7:123,583,062...123,586,919
JBrowse link
G Ndufaf6 NADH:ubiquinone oxidoreductase complex assembly factor 6 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NDUFAF6 mRNA CTD PMID:17183730 NCBI chr 5:24,297,169...24,320,804
Ensembl chr 5:24,297,094...24,320,786
JBrowse link
G Ndufb1 NADH:ubiquinone oxidoreductase subunit B1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NDUFB1 mRNA CTD PMID:17183730 NCBI chr 6:125,861,219...125,870,231 JBrowse link
G Ndufb10 NADH:ubiquinone oxidoreductase subunit B10 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NDUFB10 mRNA CTD PMID:17183730 NCBI chr10:14,090,128...14,092,289
Ensembl chr10:14,090,128...14,092,289
JBrowse link
G Ndufb2 NADH:ubiquinone oxidoreductase subunit B2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NDUFB2 mRNA CTD PMID:17183730 NCBI chr 4:67,378,188...67,385,267
Ensembl chr 4:67,378,188...67,385,266
JBrowse link
G Ndufs5 NADH:ubiquinone oxidoreductase subunit S5 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NDUFS5 mRNA CTD PMID:17183730 NCBI chr 5:141,390,577...141,405,507
Ensembl chr 5:141,390,580...141,405,453
JBrowse link
G Nedd1 NEDD1 gamma-tubulin ring complex targeting factor multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NEDD1 mRNA CTD PMID:17183730 NCBI chr 7:33,544,097...33,584,406
Ensembl chr 7:33,543,828...33,584,564
JBrowse link
G Net1 neuroepithelial cell transforming 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of NET1 mRNA CTD PMID:17183730 NCBI chr17:69,991,786...70,020,977
Ensembl chr17:70,010,794...70,020,982
JBrowse link
G Nf1 neurofibromin 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NF1 mRNA CTD PMID:17183730 NCBI chr10:66,732,460...66,928,706
Ensembl chr10:66,690,133...66,928,903
JBrowse link
G Nfatc2 nuclear factor of activated T-cells 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NFATC2 mRNA CTD PMID:17183730 NCBI chr 3:165,241,750...165,374,644
Ensembl chr 3:165,245,238...165,360,292
JBrowse link
G Nhlrc2 NHL repeat containing 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of NHLRC2 mRNA CTD PMID:17183730 NCBI chr 1:277,355,619...277,415,940
Ensembl chr 1:277,355,619...277,415,907
JBrowse link
G Nhs NHS actin remodeling regulator multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NHS mRNA CTD PMID:17183730 NCBI chr  X:34,312,102...34,675,912
Ensembl chr  X:34,623,405...34,673,742
JBrowse link
G Nmd3 NMD3 ribosome export adaptor multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NMD3 mRNA CTD PMID:17183730 NCBI chr 2:166,402,838...166,428,331
Ensembl chr 2:166,402,838...166,428,331
JBrowse link
G Nme1 NME/NM23 nucleoside diphosphate kinase 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NME1 mRNA CTD PMID:17183730 NCBI chr10:81,657,152...81,666,542
Ensembl chr10:81,657,153...81,666,523
JBrowse link
G Nod1 nucleotide-binding oligomerization domain containing 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NOD1 mRNA CTD PMID:17183730 NCBI chr 4:85,123,965...85,175,206
Ensembl chr 4:85,123,960...85,174,951
JBrowse link
G Nos1 nitric oxide synthase 1 increases expression EXP Hydralazine results in increased expression of NOS1 mRNA CTD PMID:7533141 NCBI chr12:44,214,949...44,405,530
Ensembl chr12:44,213,943...44,520,341
JBrowse link
G Nova1 NOVA alternative splicing regulator 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NOVA1 mRNA CTD PMID:17183730 NCBI chr 6:66,960,126...67,085,836
Ensembl chr 6:66,963,510...67,085,390
JBrowse link
G Npas3 neuronal PAS domain protein 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NPAS3 mRNA CTD PMID:17183730 NCBI chr 6:74,081,995...74,913,025 JBrowse link
G Npdc1 neural proliferation, differentiation and control, 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NPDC1 mRNA CTD PMID:17183730 NCBI chr 3:2,624,231...2,630,672
Ensembl chr 3:2,625,015...2,630,670
JBrowse link
G Nphp4 nephrocystin 4 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NPHP4 mRNA CTD PMID:17183730 NCBI chr 5:169,647,581...169,744,662
Ensembl chr 5:169,659,188...169,744,660
JBrowse link
G Nppb natriuretic peptide B multiple interactions EXP Hydralazine inhibits the reaction [Nitric Oxide deficiency results in increased expression of NPPB mRNA] CTD PMID:16326922 NCBI chr 5:164,796,176...164,797,538
Ensembl chr 5:164,796,185...164,797,531
JBrowse link
G Npr1 natriuretic peptide receptor 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NPR1 mRNA CTD PMID:17183730 NCBI chr 2:189,840,403...189,857,032
Ensembl chr 2:189,840,403...189,856,090
JBrowse link
G Nr1h3 nuclear receptor subfamily 1, group H, member 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NR1H3 mRNA CTD PMID:17183730 NCBI chr 3:80,004,130...80,014,197
Ensembl chr 3:80,004,130...80,012,750
JBrowse link
G Nr2c2 nuclear receptor subfamily 2, group C, member 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NR2C2 mRNA CTD PMID:17183730 NCBI chr 4:124,005,287...124,030,349
Ensembl chr 4:124,005,280...124,030,349
JBrowse link
G Nr3c1 nuclear receptor subfamily 3, group C, member 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NR3C1 mRNA CTD PMID:17183730 NCBI chr18:31,728,373...32,704,022
Ensembl chr18:31,728,373...31,749,647
JBrowse link
G Nrep neuronal regeneration related protein multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NREP mRNA CTD PMID:17183730 NCBI chr18:26,183,753...26,212,796
Ensembl chr18:26,185,259...26,211,445
JBrowse link
G Nrxn2 neurexin 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NRXN2 mRNA CTD PMID:17183730 NCBI chr 1:221,792,191...221,908,047
Ensembl chr 1:221,792,221...221,908,049
JBrowse link
G Nsdhl NAD(P) dependent steroid dehydrogenase-like multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NSDHL mRNA CTD PMID:17183730 NCBI chr  X:152,933,118...152,964,399
Ensembl chr  X:152,933,069...152,964,390
JBrowse link
G Nsfl1c NSFL1 cofactor multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NSFL1C mRNA CTD PMID:17183730 NCBI chr 3:146,980,923...147,005,478
Ensembl chr 3:146,980,923...147,005,439
JBrowse link
G Nsun4 NOP2/Sun RNA methyltransferase 4 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NSUN4 mRNA CTD PMID:17183730 NCBI chr 5:134,885,377...134,905,492
Ensembl chr 5:134,886,497...134,905,588
JBrowse link
G Ntan1 N-terminal asparagine amidase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NTAN1 mRNA CTD PMID:17183730 NCBI chr10:3,218,414...3,235,229 JBrowse link
G Ntsr2 neurotensin receptor 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of NTSR2 mRNA CTD PMID:17183730 NCBI chr 6:41,917,065...41,923,780
Ensembl chr 6:41,917,132...41,923,542
JBrowse link
G Nudc nuclear distribution C, dynein complex regulator multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NUDC mRNA CTD PMID:17183730 NCBI chr 5:151,754,723...151,768,104
Ensembl chr 5:151,754,716...151,768,123
JBrowse link
G Nudt7 nudix hydrolase 7 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of NUDT7 mRNA CTD PMID:17183730 NCBI chr19:46,455,745...46,470,070
Ensembl chr19:46,455,761...46,482,050
JBrowse link
G Numb NUMB, endocytic adaptor protein multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NUMB mRNA CTD PMID:17183730 NCBI chr 6:107,279,917...107,325,345
Ensembl chr 6:107,279,920...107,325,345
JBrowse link
G Nup153 nucleoporin 153 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NUP153 mRNA CTD PMID:17183730 NCBI chr17:18,358,712...18,411,368
Ensembl chr17:18,358,712...18,411,368
JBrowse link
G Nupr1 nuclear protein 1, transcriptional regulator multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NUPR1 mRNA CTD PMID:17183730 NCBI chr 1:194,767,484...194,769,519
Ensembl chr 1:194,767,474...194,769,524
JBrowse link
G Nxph3 neurexophilin 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of NXPH3 mRNA CTD PMID:17183730 NCBI chr10:83,329,263...83,332,929
Ensembl chr10:83,328,410...83,332,851
JBrowse link
G Oaz1 ornithine decarboxylase antizyme 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of OAZ1 mRNA CTD PMID:17183730 NCBI chr 7:11,752,127...11,754,587
Ensembl chr 7:11,752,412...11,754,508
JBrowse link
G Obscn obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of OBSCN mRNA CTD PMID:17183730 NCBI chr10:45,353,185...45,483,570
Ensembl chr10:45,338,009...45,481,008
JBrowse link
G Ociad2 OCIA domain containing 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of OCIAD2 mRNA CTD PMID:17183730 NCBI chr14:37,432,999...37,449,425
Ensembl chr14:37,435,654...37,444,775
JBrowse link
G Ofcc1 orofacial cleft 1 candidate 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of OFCC1 mRNA CTD PMID:17183730 NCBI chr17:25,080,754...25,440,075
Ensembl chr17:25,228,437...25,439,938
JBrowse link
G Oga O-GlcNAcase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of OGA mRNA CTD PMID:17183730 NCBI chr 1:265,506,752...265,542,452
Ensembl chr 1:265,507,451...265,542,276
JBrowse link
G Ogg1 8-oxoguanine DNA glycosylase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of OGG1 mRNA CTD PMID:17183730 NCBI chr 4:145,282,828...145,289,367
Ensembl chr 4:145,282,797...145,289,326
JBrowse link
G Ogt O-linked N-acetylglucosamine (GlcNAc) transferase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of OGT mRNA CTD PMID:17183730 NCBI chr  X:71,540,870...71,585,906
Ensembl chr  X:71,528,988...71,585,908
JBrowse link
G Olr384 olfactory receptor 384 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of OR9I1 mRNA CTD PMID:17183730 NCBI chr 1:230,811,800...230,812,750
Ensembl chr 1:230,811,800...230,812,750
JBrowse link
G Opa1 OPA1, mitochondrial dynamin like GTPase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of OPA1 mRNA CTD PMID:17183730 NCBI chr11:74,717,600...74,793,902
Ensembl chr11:74,720,254...74,793,803
JBrowse link
G Oprd1 opioid receptor, delta 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of OPRD1 mRNA CTD PMID:17183730 NCBI chr 5:150,288,126...150,323,063
Ensembl chr 5:150,288,126...150,323,063
JBrowse link
G P2rx3 purinergic receptor P2X 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of P2RX3 mRNA CTD PMID:17183730 NCBI chr 3:72,403,992...72,447,801
Ensembl chr 3:72,403,993...72,447,801
JBrowse link
G Pafah1b3 platelet-activating factor acetylhydrolase 1b, catalytic subunit 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PAFAH1B3 mRNA CTD PMID:17183730 NCBI chr 1:82,163,733...82,166,259
Ensembl chr 1:82,163,595...82,166,363
JBrowse link
G Park7 Parkinsonism associated deglycase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PARK7 mRNA CTD PMID:17183730 NCBI chr 5:167,982,438...168,004,724
Ensembl chr 5:167,982,439...168,004,724
JBrowse link
G Parp1 poly (ADP-ribose) polymerase 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PARP1 mRNA CTD PMID:17183730 NCBI chr13:98,857,255...98,889,444
Ensembl chr13:98,857,177...98,889,716
JBrowse link
G Parp14 poly (ADP-ribose) polymerase family, member 14 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PARP14 mRNA CTD PMID:17183730 NCBI chr11:68,105,442...68,137,509
Ensembl chr11:68,105,369...68,137,535
JBrowse link
G Pasd1 PAS domain containing repressor 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PASD1 mRNA CTD PMID:17183730 NCBI chr16:70,001,708...70,006,009
NCBI chr16:70,011,911...70,027,313
Ensembl chr16:70,002,883...70,006,016
Ensembl chr16:70,002,883...70,006,016
JBrowse link
G Pbx2 PBX homeobox 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PBX2 mRNA CTD PMID:17183730 NCBI chr20:4,357,805...4,362,730
Ensembl chr20:4,357,733...4,362,682
JBrowse link
G Pcbd1 pterin-4 alpha-carbinolamine dehydratase 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PCBD1 mRNA CTD PMID:17183730 NCBI chr20:30,689,690...30,696,465
Ensembl chr20:30,690,810...30,696,476
JBrowse link
G Pccb propionyl-CoA carboxylase subunit beta multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PCCB mRNA CTD PMID:17183730 NCBI chr 8:109,368,887...109,418,871
Ensembl chr 8:109,368,624...109,418,872
JBrowse link
G Pcdh15 protocadherin related 15 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PCDH15 mRNA CTD PMID:17183730 NCBI chr20:14,952,213...15,334,745
Ensembl chr20:14,952,213...15,334,745
JBrowse link
G Pcna proliferating cell nuclear antigen multiple interactions EXP [troglitazone co-treated with [Hydrochlorothiazide co-treated with Hydralazine co-treated with Reserpine]] results in decreased expression of PCNA protein CTD PMID:11318962 NCBI chr 3:124,880,698...124,884,570
Ensembl chr 3:124,880,698...124,884,570
JBrowse link
G Pebp4 phosphatidylethanolamine binding protein 4 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PEBP4 mRNA CTD PMID:17183730 NCBI chr15:51,644,948...51,740,626
NCBI chr15:51,528,587...51,615,204
JBrowse link
G Pfkfb4 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PFKFB4 mRNA CTD PMID:17183730 NCBI chr 8:117,733,347...117,776,525
Ensembl chr 8:117,737,117...117,775,386
JBrowse link
G Pfn1 profilin 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PFN1 mRNA CTD PMID:17183730 NCBI chr10:57,273,003...57,275,708
Ensembl chr10:57,273,005...57,275,708
JBrowse link
G Pgam2 phosphoglycerate mutase 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PGAM2 mRNA CTD PMID:17183730 NCBI chr14:86,045,005...86,047,116
Ensembl chr14:86,044,969...86,047,162
JBrowse link
G Pgm1 phosphoglucomutase 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PGM1 mRNA CTD PMID:17183730 NCBI chr 5:118,743,632...118,803,055
Ensembl chr 5:118,743,632...118,803,055
JBrowse link
G Phb prohibitin multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PHB mRNA CTD PMID:17183730 NCBI chr10:83,476,107...83,488,878
Ensembl chr10:83,476,107...83,488,878
JBrowse link
G Phc1 polyhomeotic homolog 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of PHC1 mRNA CTD PMID:17183730 NCBI chr 4:155,093,947...155,118,838
Ensembl chr 4:155,093,949...155,116,154
JBrowse link
G Phc2 polyhomeotic homolog 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PHC2 mRNA CTD PMID:17183730 NCBI chr 5:146,832,552...146,931,444
Ensembl chr 5:146,882,756...146,931,444
JBrowse link
G Phf24 PHD finger protein 24 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PHF24 mRNA CTD PMID:17183730 NCBI chr 5:58,359,744...58,387,446
Ensembl chr 5:58,359,498...58,383,070
JBrowse link
G Pigs phosphatidylinositol glycan anchor biosynthesis, class S multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PIGS mRNA CTD PMID:17183730 NCBI chr10:65,591,638...65,606,175
Ensembl chr10:65,591,622...65,606,202
JBrowse link
G Pip prolactin induced protein multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PIP mRNA CTD PMID:17183730 NCBI chr 4:71,320,859...71,325,153
Ensembl chr 4:71,320,859...71,325,153
JBrowse link
G Plcg1 phospholipase C, gamma 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PLCG1 mRNA CTD PMID:17183730 NCBI chr 3:156,727,642...156,758,307
Ensembl chr 3:156,727,642...156,758,307
JBrowse link
G Plrg1 pleiotropic regulator 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PLRG1 mRNA CTD PMID:17183730 NCBI chr 2:182,040,338...182,056,669
Ensembl chr 2:182,040,318...182,056,673
JBrowse link
G Plxdc1 plexin domain containing 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PLXDC1 mRNA CTD PMID:17183730 NCBI chr10:85,871,122...85,938,085
Ensembl chr10:85,871,122...85,938,085
JBrowse link
G Pmm2 phosphomannomutase 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PMM2 mRNA CTD PMID:17183730 NCBI chr10:7,056,258...7,077,443
Ensembl chr10:7,056,266...7,077,443
JBrowse link
G Pmvk phosphomevalonate kinase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PMVK mRNA CTD PMID:17183730 NCBI chr 2:188,784,329...188,793,890
Ensembl chr 2:188,784,222...188,793,895
JBrowse link
G Pole4 DNA polymerase epsilon 4, accessory subunit multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of POLE4 mRNA CTD PMID:17183730 NCBI chr 4:113,491,644...113,497,455
Ensembl chr 4:113,491,644...113,497,455
JBrowse link
G Polr2l RNA polymerase II, I and III subunit L multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of POLR2L mRNA CTD PMID:17183730 NCBI chr 1:214,451,966...214,453,974 JBrowse link
G Pop5 POP5 homolog, ribonuclease P/MRP subunit multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of POP5 mRNA CTD PMID:17183730 NCBI chr12:47,138,346...47,143,152
Ensembl chr12:47,138,346...47,142,852
JBrowse link
G Ppil4 peptidylprolyl isomerase like 4 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PPIL4 mRNA CTD PMID:17183730 NCBI chr 1:1,897,316...1,930,311
Ensembl chr 1:1,897,338...1,929,763
JBrowse link
G Ppp1r12a protein phosphatase 1, regulatory subunit 12A multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PPP1R12A mRNA CTD PMID:17183730 NCBI chr 7:51,404,971...51,515,382
Ensembl chr 7:51,404,919...51,515,373
JBrowse link
G Ppp1r9a protein phosphatase 1, regulatory subunit 9A multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PPP1R9A mRNA CTD PMID:17183730 NCBI chr 4:29,976,485...30,247,371
Ensembl chr 4:29,978,739...30,241,911
JBrowse link
G Ppp2r1b protein phosphatase 2 scaffold subunit A beta multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PPP2R1B mRNA CTD PMID:17183730 NCBI chr 8:55,279,278...55,311,768
Ensembl chr 8:55,279,373...55,301,320
JBrowse link
G Prkcsh protein kinase C substrate 80K-H multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PRKCSH mRNA CTD PMID:17183730 NCBI chr 8:23,014,802...23,026,507
Ensembl chr 8:23,014,956...23,026,503
JBrowse link
G Prkg1 protein kinase cGMP-dependent 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PRKG1 mRNA CTD PMID:17183730 NCBI chr 1:248,982,039...250,300,952 JBrowse link
G Prom2 prominin 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PROM2 mRNA CTD PMID:17183730 NCBI chr 3:120,087,633...120,107,495
Ensembl chr 3:120,092,582...120,106,697
JBrowse link
G Prpf18 pre-mRNA processing factor 18 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PRPF18 mRNA CTD PMID:17183730 NCBI chr17:77,601,914...77,632,507
Ensembl chr17:77,601,877...77,663,980
JBrowse link
G Prr13 proline rich 13 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PRR13 mRNA CTD PMID:17183730 NCBI chr 7:144,064,931...144,068,235
Ensembl chr 7:144,064,931...144,098,101
JBrowse link
G Prtfdc1 phosphoribosyl transferase domain containing 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PRTFDC1 mRNA CTD PMID:17183730 NCBI chr17:87,926,242...88,037,040
Ensembl chr17:87,927,058...88,037,040
JBrowse link
G Psd3 pleckstrin and Sec7 domain containing 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PSD3 mRNA CTD PMID:17183730 NCBI chr16:23,212,165...23,789,414
Ensembl chr16:23,447,366...23,781,604
JBrowse link
G Psma2 proteasome 20S subunit alpha 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PSMA2 mRNA CTD PMID:17183730 NCBI chr17:53,091,937...53,102,324
Ensembl chr17:53,091,933...53,102,342
JBrowse link
G Psma4 proteasome 20S subunit alpha 4 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PSMA4 mRNA CTD PMID:17183730 NCBI chr 8:59,532,456...59,539,916
Ensembl chr 8:59,532,389...59,539,920
JBrowse link
G Psmb1 proteasome 20S subunit beta 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PSMB1 mRNA CTD PMID:17183730 NCBI chr 1:57,470,878...57,491,359
Ensembl chr 1:57,470,632...57,489,727
JBrowse link
G Psmb2 proteasome 20S subunit beta 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PSMB2 mRNA CTD PMID:17183730 NCBI chr 5:144,702,004...144,734,220
Ensembl chr 5:144,701,949...144,734,257
JBrowse link
G Psmb3 proteasome 20S subunit beta 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PSMB3 mRNA CTD PMID:17183730 NCBI chr10:85,646,646...85,653,729
Ensembl chr10:85,646,633...85,653,729
JBrowse link
G Psmb6 proteasome 20S subunit beta 6 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PSMB6 mRNA CTD PMID:17183730 NCBI chr10:57,131,339...57,133,685
Ensembl chr10:57,131,386...57,133,637
JBrowse link
G Psmb9 proteasome 20S subunit beta 9 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PSMB9 mRNA CTD PMID:17183730 NCBI chr20:3,973,424...3,978,845
Ensembl chr20:3,973,420...3,978,845
JBrowse link
G Psmc6 proteasome 26S subunit, ATPase 6 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PSMC6 mRNA CTD PMID:17183730 NCBI chr15:19,667,453...19,688,916
Ensembl chr15:19,667,453...19,688,914
JBrowse link
G Psmd1 proteasome 26S subunit, non-ATPase 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PSMD1 mRNA CTD PMID:17183730 NCBI chr 9:93,080,618...93,155,033
Ensembl chr 9:93,080,615...93,155,027
JBrowse link
G Psmd3 proteasome 26S subunit, non-ATPase 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of PSMD3 mRNA CTD PMID:17183730 NCBI chr10:86,599,007...86,611,180
Ensembl chr10:86,599,220...86,611,188
JBrowse link
G Psmd4 proteasome 26S subunit, non-ATPase 4 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PSMD4 mRNA CTD PMID:17183730 NCBI chr 2:196,198,303...196,207,569
Ensembl chr 2:196,198,038...196,207,560
JBrowse link
G Psmd8 proteasome 26S subunit, non-ATPase 8 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PSMD8 mRNA CTD PMID:17183730 NCBI chr 1:88,116,811...88,123,643
Ensembl chr 1:88,116,812...88,123,643
JBrowse link
G Psmg3 proteasome assembly chaperone 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PSMG3 mRNA CTD PMID:17183730 NCBI chr12:16,898,999...16,901,945
Ensembl chr12:16,899,025...16,901,934
JBrowse link
G Ptk2b protein tyrosine kinase 2 beta multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PTK2B mRNA CTD PMID:17183730 NCBI chr15:42,827,306...42,947,796
Ensembl chr15:42,827,310...42,947,656
JBrowse link
G Ptma prothymosin alpha multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PTMA mRNA CTD PMID:17183730 NCBI chr 9:93,545,396...93,549,436
Ensembl chr 9:93,545,396...93,549,436
JBrowse link
G Ptprj protein tyrosine phosphatase, receptor type, J multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PTPRJ mRNA CTD PMID:17183730 NCBI chr 3:79,233,519...79,390,956
Ensembl chr 3:79,233,525...79,390,956
JBrowse link
G Puf60 poly-U binding splicing factor 60 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PUF60 mRNA CTD PMID:17183730 NCBI chr 7:117,129,237...117,140,234
Ensembl chr 7:117,129,237...117,140,214
JBrowse link
G Pum1 pumilio RNA-binding family member 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PUM1 mRNA CTD PMID:17183730 NCBI chr 5:148,781,239...148,911,776
Ensembl chr 5:148,781,222...148,911,803
JBrowse link
G Pycard PYD and CARD domain containing multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PYCARD mRNA CTD PMID:17183730 NCBI chr 1:199,438,029...199,439,062
Ensembl chr 1:199,437,832...199,439,210
JBrowse link
G Pycr3 pyrroline-5-carboxylate reductase 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of PYCR3 mRNA CTD PMID:17183730 NCBI chr 7:116,949,882...116,955,150
Ensembl chr 7:116,949,879...116,955,148
JBrowse link
G Rab13 RAB13, member RAS oncogene family multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RAB13 mRNA CTD PMID:17183730 NCBI chr 2:189,581,209...189,586,358
Ensembl chr 2:189,581,644...189,586,338
JBrowse link
G Rab1a RAB1A, member RAS oncogene family multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RAB1A mRNA CTD PMID:17183730 NCBI chr14:104,475,082...104,500,176
Ensembl chr14:104,475,082...104,501,020
JBrowse link
G Rab30 RAB30, member RAS oncogene family multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RAB30 mRNA CTD PMID:17183730 NCBI chr 1:157,573,344...157,667,973
Ensembl chr 1:157,573,324...157,660,008
JBrowse link
G Rab3a RAB3A, member RAS oncogene family multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RAB3A mRNA CTD PMID:17183730 NCBI chr16:20,435,098...20,439,206
Ensembl chr16:20,435,101...20,439,206
JBrowse link
G Rab3d RAB3D, member RAS oncogene family multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RAB3D mRNA CTD PMID:17183730 NCBI chr 8:22,920,238...22,929,368
Ensembl chr 8:22,918,699...22,929,294
JBrowse link
G Rab6a RAB6A, member RAS oncogene family multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RAB6A mRNA CTD PMID:17183730 NCBI chr 1:165,624,973...165,664,201
Ensembl chr 1:165,625,058...165,664,192
JBrowse link
G Rabep2 rabaptin, RAB GTPase binding effector protein 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RABEP2 mRNA CTD PMID:17183730 NCBI chr 1:197,839,583...197,855,953
Ensembl chr 1:197,839,430...197,856,312
JBrowse link
G Rabgef1 RAB guanine nucleotide exchange factor 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RABGEF1 mRNA CTD PMID:17183730 NCBI chr12:29,960,132...30,004,727
Ensembl chr12:29,961,120...29,988,959
JBrowse link
G Rad21 RAD21 cohesin complex component multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RAD21 mRNA CTD PMID:17183730 NCBI chr 7:91,511,755...91,538,673
Ensembl chr 7:91,511,756...91,538,673
JBrowse link
G Ralgds ral guanine nucleotide dissociation stimulator multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RALGDS mRNA CTD PMID:17183730 NCBI chr 3:7,090,134...7,130,548
Ensembl chr 3:7,109,920...7,130,548
JBrowse link
G Ralgps1 Ral GEF with PH domain and SH3 binding motif 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RALGPS1 mRNA CTD PMID:17183730 NCBI chr 3:12,182,722...12,415,081
Ensembl chr 3:12,178,853...12,415,073
JBrowse link
G Ramp2 receptor activity modifying protein 2 multiple interactions EXP Hydralazine inhibits the reaction [Nitric Oxide deficiency results in increased expression of RAMP2 protein] CTD PMID:16326922 NCBI chr10:89,166,170...89,168,962
Ensembl chr10:89,166,890...89,168,965
JBrowse link
G Ramp3 receptor activity modifying protein 3 multiple interactions EXP Hydralazine inhibits the reaction [Nitric Oxide deficiency results in increased expression of RAMP3 protein] CTD PMID:16326922 NCBI chr14:86,922,223...86,939,722
Ensembl chr14:86,922,223...86,939,719
JBrowse link
G Rap1a RAP1A, member of RAS oncogene family multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RAP1A mRNA CTD PMID:17183730 NCBI chr 2:208,193,950...208,215,186
Ensembl chr 2:208,193,954...208,215,187
JBrowse link
G Rarb retinoic acid receptor, beta decreases methylation ISO Hydralazine results in decreased methylation of RARB promoter CTD PMID:15862127 NCBI chr15:9,915,223...10,262,599
Ensembl chr15:10,120,206...10,262,599
JBrowse link
G Rbl1 RB transcriptional corepressor like 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RBL1 mRNA CTD PMID:17183730 NCBI chr 3:153,263,692...153,321,351
Ensembl chr 3:153,263,692...153,321,352
JBrowse link
G Rbm22 RNA binding motif protein 22 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RBM22 mRNA CTD PMID:17183730 NCBI chr18:55,828,158...55,839,421
Ensembl chr18:55,828,158...55,838,966
JBrowse link
G Rbm4 RNA binding motif protein 4 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RBM4 mRNA CTD PMID:17183730 NCBI chr 1:220,038,403...220,049,756
Ensembl chr 1:220,039,734...220,048,966
JBrowse link
G Rcl1 RNA terminal phosphate cyclase-like 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RCL1 mRNA CTD PMID:17183730 NCBI chr 1:247,228,012...247,272,369
Ensembl chr 1:247,228,061...247,305,693
JBrowse link
G Reep4 receptor accessory protein 4 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of REEP4 mRNA CTD PMID:17183730 NCBI chr15:52,235,283...52,238,490
Ensembl chr15:52,234,563...52,238,471
JBrowse link
G Reg1a regenerating family member 1 alpha multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of REG1A mRNA CTD PMID:17183730 NCBI chr 4:109,497,962...109,500,626
Ensembl chr 4:109,497,962...109,501,082
JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit multiple interactions ISO Hydralazine inhibits the reaction [Acrolein promotes the reaction [RELA protein binds to FASLG promoter]]; Hydralazine inhibits the reaction [Acrolein promotes the reaction [Zidovudine promotes the reaction [RELA protein binds to FASLG promoter]]]; Hydralazine inhibits the reaction [Zidovudine promotes the reaction [Acrolein promotes the reaction [RELA protein binds to FASLG promoter]]]; Hydralazine inhibits the reaction [Zidovudine promotes the reaction [RELA protein binds to FASLG promoter]] CTD PMID:27238871 NCBI chr 1:220,992,770...221,003,249
Ensembl chr 1:220,992,770...221,003,249
JBrowse link
G Ren renin multiple interactions
increases activity
increases expression
ISO
EXP
Alprenolol inhibits the reaction [Hydralazine results in increased expression of REN protein]
Hydralazine results in increased activity of REN protein
CTD PMID:231700, PMID:923630, PMID:2203898, PMID:2953239, PMID:3154321 NCBI chr13:50,502,724...50,513,953
Ensembl chr13:50,502,724...50,514,151
JBrowse link
G Rer1 retention in endoplasmic reticulum sorting receptor 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RER1 mRNA CTD PMID:17183730 NCBI chr 5:172,476,746...172,488,822
Ensembl chr 5:172,476,747...172,488,822
JBrowse link
G Rfx1 regulatory factor X1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RFX1 mRNA CTD PMID:17183730 NCBI chr19:25,181,564...25,212,410
Ensembl chr19:25,181,564...25,212,410
JBrowse link
G RGD1561662 similar to AI661453 protein multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of C6ORF132 mRNA CTD PMID:17183730 NCBI chr 9:15,545,460...15,582,567
Ensembl chr 9:15,546,823...15,582,556
JBrowse link
G Rgs7bp regulator of G-protein signaling 7 binding protein multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RGS7BP mRNA CTD PMID:17183730 NCBI chr 2:35,072,081...35,619,085
Ensembl chr 2:35,077,504...35,104,963
JBrowse link
G Rgs9 regulator of G-protein signaling 9 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RGS9 mRNA CTD PMID:17183730 NCBI chr10:97,509,971...97,582,188
Ensembl chr10:97,509,971...97,582,188
JBrowse link
G Rgs9bp regulator of G protein signaling 9 binding protein multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RGS9BP mRNA CTD PMID:17183730 NCBI chr 1:91,855,270...91,855,983
Ensembl chr 1:91,855,270...91,855,983
JBrowse link
G Rin3 Ras and Rab interactor 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RIN3 mRNA CTD PMID:17183730 NCBI chr 6:126,170,672...126,279,682
Ensembl chr 6:126,170,720...126,279,682
JBrowse link
G Rinl Ras and Rab interactor-like multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RINL mRNA CTD PMID:17183730 NCBI chr 1:86,971,997...86,983,306
Ensembl chr 1:86,972,244...86,983,514
JBrowse link
G Ripk1 receptor interacting serine/threonine kinase 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RIPK1 mRNA CTD PMID:17183730 NCBI chr17:31,537,580...31,569,904
Ensembl chr17:31,537,591...31,569,904
JBrowse link
G Ripply1 ripply transcriptional repressor 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RIPPLY1 mRNA CTD PMID:17183730 NCBI chr  X:111,099,420...111,114,835
Ensembl chr  X:111,099,930...111,102,464
JBrowse link
G Rmnd5b required for meiotic nuclear division 5 homolog B multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RMND5B mRNA CTD PMID:17183730 NCBI chr10:34,979,902...34,990,985
Ensembl chr10:34,979,923...34,990,943
JBrowse link
G Rnf152 ring finger protein 152 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RNF152 mRNA CTD PMID:17183730 NCBI chr13:25,183,295...25,262,785
Ensembl chr13:25,186,106...25,262,469
JBrowse link
G Rnf187 ring finger protein 187 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RNF187 mRNA CTD PMID:17183730 NCBI chr10:45,273,400...45,279,299
Ensembl chr10:45,273,400...45,279,299
JBrowse link
G Robo2 roundabout guidance receptor 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ROBO2 mRNA CTD PMID:17183730 NCBI chr11:11,062,866...12,618,793
Ensembl chr11:11,062,790...11,585,765
JBrowse link
G Romo1 reactive oxygen species modulator 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ROMO1 mRNA CTD PMID:17183730 NCBI chr 3:151,688,213...151,689,813
Ensembl chr 3:151,688,454...151,689,711
JBrowse link
G Rpl10a ribosomal protein L10A multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RPL10A mRNA CTD PMID:17183730 NCBI chr20:7,908,309...7,910,867
Ensembl chr20:7,908,304...7,910,867
JBrowse link
G Rpl13 ribosomal protein L13 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RPL13 mRNA CTD PMID:17183730 NCBI chr19:55,917,489...55,920,040
Ensembl chr19:55,917,736...55,919,996
JBrowse link
G Rpl17 ribosomal protein L17 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RPL17 mRNA CTD PMID:17183730 NCBI chr18:70,969,733...70,972,839
Ensembl chr18:70,970,596...70,975,494
JBrowse link
G Rpl18a ribosomal protein L18A multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RPL18A mRNA CTD PMID:17183730 NCBI chr16:20,293,277...20,295,283
Ensembl chr16:20,293,229...20,295,294
JBrowse link
G Rpl23a ribosomal protein L23a multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RPL23A mRNA CTD PMID:17183730 NCBI chr10:65,441,295...65,443,981
Ensembl chr10:65,441,295...65,443,981
JBrowse link
G Rpl24 ribosomal protein L24 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RPL24 mRNA CTD PMID:17183730 NCBI chr11:47,116,885...47,122,093
Ensembl chr11:47,116,886...47,122,095
JBrowse link
G Rpl26 ribosomal protein L26 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RPL26 mRNA CTD PMID:17183730 NCBI chr10:55,492,417...55,495,547
Ensembl chr10:55,492,404...55,496,012
JBrowse link
G Rpl27 ribosomal protein L27 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RPL27 mRNA CTD PMID:17183730 NCBI chr10:89,352,864...89,356,563
Ensembl chr10:89,352,835...89,356,547
JBrowse link
G Rpl31 ribosomal protein L31 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RPL31 mRNA CTD PMID:17183730 NCBI chr 9:46,086,959...46,090,444
Ensembl chr 9:46,086,984...46,090,997
JBrowse link
G Rpl34 ribosomal protein L34 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RPL34 mRNA CTD PMID:17183730 NCBI chr 2:235,850,281...235,854,021
Ensembl chr 2:235,850,334...235,852,708
JBrowse link
G Rpl36 ribosomal protein L36 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RPL36 mRNA CTD PMID:17183730 NCBI chr 9:10,441,228...10,441,981
Ensembl chr 9:10,441,259...10,441,834
JBrowse link
G Rpl37a ribosomal protein L37a multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RPL37A mRNA CTD PMID:17183730 NCBI chr 9:80,002,892...80,004,995 JBrowse link
G Rpl39 ribosomal protein L39 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RPL39 mRNA CTD PMID:17183730 NCBI chr  X:123,705,241...123,707,257
Ensembl chr  X:123,705,235...123,708,211
JBrowse link
G Rpl41 ribosomal protein L41 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RPL41 mRNA CTD PMID:17183730 NCBI chr 7:2,972,897...2,973,977
Ensembl chr 7:2,972,900...2,973,977
JBrowse link
G Rpl7 ribosomal protein L7 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RPL7 mRNA CTD PMID:17183730 NCBI chr 5:2,633,517...2,636,525
Ensembl chr 5:2,632,712...2,640,021
JBrowse link
G Rplp1 ribosomal protein lateral stalk subunit P1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RPLP1 mRNA CTD PMID:17183730 NCBI chr 8:66,862,143...66,863,476
Ensembl chr 8:66,862,143...66,863,476
JBrowse link
G Rpp21 ribonuclease P/MRP subunit p21 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RPP21 mRNA CTD PMID:17183730 NCBI chr20:2,515,541...2,517,471
Ensembl chr20:2,515,520...2,517,498
JBrowse link
G Rps11 ribosomal protein S11 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RPS11 mRNA CTD PMID:17183730 NCBI chr 1:101,116,641...101,118,749
Ensembl chr 1:101,116,635...101,118,825
JBrowse link
G Rps12 ribosomal protein S12 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RPS12 mRNA CTD PMID:17183730 NCBI chr 1:22,758,214...22,760,370
Ensembl chr 1:22,758,212...22,760,370
JBrowse link
G Rps19bp1 ribosomal protein S19 binding protein 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RPS19BP1 mRNA CTD PMID:17183730 NCBI chr 7:121,488,453...121,489,075
Ensembl chr 7:121,485,800...121,489,078
JBrowse link
G Rps2 ribosomal protein S2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RPS2 mRNA CTD PMID:17183730 NCBI chr10:14,088,171...14,090,020
Ensembl chr10:14,088,319...14,089,979
JBrowse link
G Rps27 ribosomal protein S27 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RPS27 mRNA CTD PMID:17183730 NCBI chr 2:189,572,175...189,573,280
Ensembl chr 2:189,572,176...189,573,280
JBrowse link
G Rps27a ribosomal protein S27a multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RPS27A mRNA CTD PMID:17183730 NCBI chr14:113,966,163...113,968,440
Ensembl chr14:113,966,611...113,968,268
Ensembl chr 5:113,966,611...113,968,268
JBrowse link
G Rps6ka5 ribosomal protein S6 kinase A5 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RPS6KA5 mRNA CTD PMID:17183730 NCBI chr 6:124,557,892...124,735,787
Ensembl chr 6:124,557,913...124,735,778
JBrowse link
G Rps9 ribosomal protein S9 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RPS9 mRNA CTD PMID:17183730 NCBI chr 1:64,086,625...64,090,023
Ensembl chr 1:64,018,125...64,090,021
JBrowse link
G Rspo4 R-spondin 4 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RSPO4 mRNA CTD PMID:17183730 NCBI chr 3:147,358,690...147,391,719
Ensembl chr 3:147,358,858...147,389,698
JBrowse link
G Rsrp1 arginine and serine rich protein 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RSRP1 mRNA CTD PMID:17183730 NCBI chr 5:153,260,930...153,264,669
Ensembl chr 5:153,260,930...153,264,669
JBrowse link
G RT1-DOb RT1 class II, locus DOb multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of HLA-DOB mRNA CTD PMID:17183730 NCBI chr20:4,020,273...4,026,398
Ensembl chr20:4,020,317...4,026,346
JBrowse link
G Rtn4rl1 reticulon 4 receptor-like 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RTN4RL1 mRNA CTD PMID:17183730 NCBI chr10:62,035,866...62,109,075
Ensembl chr10:62,035,866...62,109,078
JBrowse link
G Rwdd1 RWD domain containing 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RWDD1 mRNA CTD PMID:17183730 NCBI chr20:27,534,361...27,552,225
Ensembl chr20:27,535,324...27,552,349
JBrowse link
G Rxrg retinoid X receptor gamma multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of RXRG mRNA CTD PMID:17183730 NCBI chr13:85,818,473...85,868,555
Ensembl chr13:85,818,427...85,868,552
JBrowse link
G S100a6 S100 calcium binding protein A6 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of S100A6 mRNA CTD PMID:17183730 NCBI chr 2:190,007,013...190,008,512
Ensembl chr 2:190,007,216...190,008,511
JBrowse link
G S100a8 S100 calcium binding protein A8 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of S100A8 mRNA CTD PMID:17183730 NCBI chr 2:190,073,239...190,074,333
Ensembl chr 2:190,073,815...190,074,354
JBrowse link
G S100pbp S100P binding protein multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of S100PBP mRNA CTD PMID:17183730 NCBI chr 5:147,333,890...147,375,151
Ensembl chr 5:147,335,242...147,375,009
JBrowse link
G Samd4a sterile alpha motif domain containing 4A multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SAMD4A mRNA CTD PMID:17183730 NCBI chr15:23,666,543...23,879,067
Ensembl chr15:23,665,202...23,878,539
JBrowse link
G Samm50 SAMM50 sorting and assembly machinery component multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SAMM50 mRNA CTD PMID:17183730 NCBI chr 7:125,058,966...125,082,506
Ensembl chr 7:125,058,897...125,082,505
JBrowse link
G Saraf store-operated calcium entry-associated regulatory factor multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SARAF mRNA CTD PMID:17183730 NCBI chr16:61,735,189...61,753,438
Ensembl chr16:61,735,181...61,753,476
JBrowse link
G Scap SREBF chaperone multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SCAP mRNA CTD PMID:17183730 NCBI chr 8:118,551,869...118,628,650
Ensembl chr 8:118,570,503...118,628,651
JBrowse link
G Scarf1 scavenger receptor class F, member 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SCARF1 mRNA CTD PMID:17183730 NCBI chr10:63,662,967...63,683,916
Ensembl chr10:63,662,986...63,670,639
JBrowse link
G Scml1 Scm polycomb group protein like 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of SCML1 mRNA CTD PMID:17183730 NCBI chr  X:34,676,728...34,694,251 JBrowse link
G Scnn1b sodium channel epithelial 1 subunit beta multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SCNN1B mRNA CTD PMID:17183730 NCBI chr 1:191,829,547...191,883,991
Ensembl chr 1:191,829,555...191,884,298
JBrowse link
G Scrn2 secernin 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SCRN2 mRNA CTD PMID:17183730 NCBI chr10:84,966,862...84,971,022
Ensembl chr10:84,966,989...84,971,009
JBrowse link
G Sdf2l1 stromal cell-derived factor 2-like 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SDF2L1 mRNA CTD PMID:17183730 NCBI chr11:88,122,271...88,124,513
Ensembl chr11:88,122,271...88,124,513
JBrowse link
G Sdhaf3 succinate dehydrogenase complex assembly factor 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SDHAF3 mRNA CTD PMID:17183730 NCBI chr 4:32,541,706...32,558,798
Ensembl chr 4:32,495,321...32,558,798
JBrowse link
G Sec11c SEC11 homolog C, signal peptidase complex subunit multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SEC11C mRNA CTD PMID:17183730 NCBI chr18:61,490,051...61,506,393
Ensembl chr18:61,490,031...61,506,508
JBrowse link
G Sec31a SEC31 homolog A, COPII coat complex component multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SEC31A mRNA CTD PMID:17183730 NCBI chr14:10,854,713...10,909,579
Ensembl chr14:10,854,682...10,909,612
JBrowse link
G Selenow selenoprotein W multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SELENOW mRNA CTD PMID:17183730 NCBI chr 1:77,530,692...77,535,765
Ensembl chr 1:77,533,148...77,535,681
Ensembl chr 1:77,533,148...77,535,681
JBrowse link
G Selplg selectin P ligand multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of SELPLG mRNA CTD PMID:17183730 NCBI chr12:48,577,905...48,579,196
Ensembl chr12:48,577,905...48,579,196
JBrowse link
G Sema4a semaphorin 4A multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SEMA4A mRNA CTD PMID:17183730 NCBI chr 2:187,799,568...187,823,014
Ensembl chr 2:187,799,568...187,822,997
JBrowse link
G Septin2 septin 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SEPTIN2 mRNA CTD PMID:17183730 NCBI chr 9:100,624,876...100,658,053
Ensembl chr 9:100,624,876...100,658,050
JBrowse link
G Serp2 stress-associated endoplasmic reticulum protein family member 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SERP2 mRNA CTD PMID:17183730 NCBI chr15:58,687,784...58,712,023
Ensembl chr15:58,687,786...58,711,872
JBrowse link
G Serpine1 serpin family E member 1 multiple interactions
decreases expression
EXP [troglitazone co-treated with [Hydrochlorothiazide co-treated with Hydralazine co-treated with Reserpine]] results in decreased expression of SERPINE1 mRNA; [troglitazone co-treated with [Hydrochlorothiazide co-treated with Hydralazine co-treated with Reserpine]] results in decreased expression of SERPINE1 protein
Hydralazine results in decreased expression of SERPINE1 mRNA
CTD PMID:11318962, PMID:23415681 NCBI chr12:22,641,104...22,651,482
Ensembl chr12:22,641,104...22,651,482
JBrowse link
G Serping1 serpin family G member 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SERPING1 mRNA CTD PMID:17183730 NCBI chr 3:72,161,230...72,171,109
Ensembl chr 3:72,161,189...72,171,078
JBrowse link
G Sertad2 SERTA domain containing 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SERTAD2 mRNA CTD PMID:17183730 NCBI chr14:104,786,649...104,890,022
Ensembl chr14:104,821,215...104,886,197
JBrowse link
G Sf1 splicing factor 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SF1 mRNA CTD PMID:17183730 NCBI chr 1:221,735,512...221,749,216
Ensembl chr 1:221,735,517...221,749,086
JBrowse link
G Sf3b6 splicing factor 3B, subunit 6 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SF3B6 mRNA CTD PMID:17183730 NCBI chr 6:29,991,232...29,999,668
Ensembl chr 6:29,991,307...29,999,410
JBrowse link
G Shank2 SH3 and multiple ankyrin repeat domains 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SHANK2 mRNA CTD PMID:17183730 NCBI chr 1:217,149,156...217,593,950
Ensembl chr 1:217,151,166...217,592,763
JBrowse link
G Shisa2 shisa family member 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SHISA2 mRNA CTD PMID:17183730 NCBI chr15:39,945,095...39,949,393
Ensembl chr15:39,945,095...39,949,393
JBrowse link
G Shoc1 shortage in chiasmata 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SHOC1 mRNA CTD PMID:17183730 NCBI chr 5:76,190,486...76,298,723 JBrowse link
G Shox2 short stature homeobox 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of SHOX2 mRNA CTD PMID:17183730 NCBI chr 2:164,118,175...164,126,783
Ensembl chr 2:164,118,191...164,126,783
JBrowse link
G Sidt2 SID1 transmembrane family, member 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SIDT2 mRNA CTD PMID:17183730 NCBI chr 8:50,230,335...50,246,979
Ensembl chr 8:50,230,339...50,246,656
JBrowse link
G Sipa1l1 signal-induced proliferation-associated 1 like 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SIPA1L1 mRNA CTD PMID:17183730 NCBI chr 6:106,052,212...106,163,249
Ensembl chr 6:106,039,991...106,163,302
JBrowse link
G Ski SKI proto-oncogene multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of SKI mRNA CTD PMID:17183730 NCBI chr 5:172,556,196...172,623,878
Ensembl chr 5:172,559,135...172,623,899
JBrowse link
G Slc12a3 solute carrier family 12 member 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SLC12A3 mRNA CTD PMID:17183730 NCBI chr19:11,106,033...11,144,674
Ensembl chr19:11,106,033...11,144,641
JBrowse link
G Slc16a2 solute carrier family 16 member 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SLC16A2 mRNA CTD PMID:17183730 NCBI chr  X:74,578,600...74,706,068
Ensembl chr  X:74,577,131...74,706,214
JBrowse link
G Slc17a9 solute carrier family 17 member 9 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SLC17A9 mRNA CTD PMID:17183730 NCBI chr 3:176,228,433...176,246,971
Ensembl chr 3:176,230,378...176,246,953
JBrowse link
G Slc19a2 solute carrier family 19 member 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SLC19A2 mRNA CTD PMID:17183730 NCBI chr13:82,552,586...82,566,586
Ensembl chr13:82,552,550...82,566,586
JBrowse link
G Slc22a16 solute carrier family 22 member 16 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SLC22A16 mRNA CTD PMID:17183730 NCBI chr20:45,658,398...45,669,192 JBrowse link
G Slc22a17 solute carrier family 22, member 17 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SLC22A17 mRNA CTD PMID:17183730 NCBI chr15:33,569,824...33,576,972
Ensembl chr15:33,569,843...33,576,331
JBrowse link
G Slc22a2 solute carrier family 22 member 2 multiple interactions ISO Hydralazine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 NCBI chr 1:48,318,025...48,360,219
Ensembl chr 1:48,317,995...48,360,261
JBrowse link
G Slc23a3 solute carrier family 23, member 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SLC23A3 mRNA CTD PMID:17183730 NCBI chr 9:82,328,007...82,338,576
Ensembl chr 9:82,328,173...82,336,806
JBrowse link
G Slc25a13 solute carrier family 25 member 13 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SLC25A13 mRNA CTD PMID:17183730 NCBI chr 4:31,134,165...31,757,006
Ensembl chr 4:31,608,269...31,730,386
JBrowse link
G Slc25a5 solute carrier family 25 member 5 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SLC25A5 mRNA CTD PMID:17183730 NCBI chr  X:123,404,570...123,407,637
Ensembl chr  X:123,404,518...123,407,645
JBrowse link
G Slc2a9 solute carrier family 2 member 9 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SLC2A9 mRNA CTD PMID:17183730 NCBI chr14:77,067,537...77,192,702
Ensembl chr14:77,067,503...77,192,702
JBrowse link
G Slc30a2 solute carrier family 30 member 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SLC30A2 mRNA CTD PMID:17183730 NCBI chr 5:152,559,577...152,571,800
Ensembl chr 5:152,559,577...152,571,799
JBrowse link
G Slc35c1 solute carrier family 35 member C1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SLC35C1 mRNA CTD PMID:17183730 NCBI chr 3:81,361,080...81,369,010
Ensembl chr 3:81,361,056...81,368,442
JBrowse link
G Slc3a2 solute carrier family 3 member 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SLC3A2 mRNA CTD PMID:17183730 NCBI chr 1:224,906,566...224,921,029
Ensembl chr 1:224,906,554...224,921,092
JBrowse link
G Slc6a13 solute carrier family 6 member 13 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SLC6A13 mRNA CTD PMID:17183730 NCBI chr 4:153,874,942...153,912,185
Ensembl chr 4:153,874,852...153,912,155
JBrowse link
G Slc6a2 solute carrier family 6 member 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SLC6A2 mRNA CTD PMID:17183730 NCBI chr19:15,391,682...15,431,274
Ensembl chr19:15,391,581...15,431,274
JBrowse link
G Slc8b1 solute carrier family 8 member B1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SLC8B1 mRNA CTD PMID:17183730 NCBI chr12:41,566,980...41,590,294
Ensembl chr12:41,566,981...41,590,244
JBrowse link
G Slirp SRA stem-loop interacting RNA binding protein multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SLIRP mRNA CTD PMID:17183730 NCBI chr 6:111,476,768...111,486,039
Ensembl chr 6:111,476,768...111,486,039
JBrowse link
G Smarcc1 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SMARCC1 mRNA CTD PMID:17183730 NCBI chr 8:118,206,678...118,326,264
Ensembl chr 8:118,206,698...118,325,537
JBrowse link
G Smo smoothened, frizzled class receptor multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SMO mRNA CTD PMID:17183730 NCBI chr 4:57,019,941...57,041,779
Ensembl chr 4:57,019,941...57,042,770
JBrowse link
G Smurf2 SMAD specific E3 ubiquitin protein ligase 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SMURF2 mRNA CTD PMID:17183730 NCBI chr10:95,018,050...95,118,107
Ensembl chr10:95,018,059...95,062,987
JBrowse link
G Snai3 snail family transcriptional repressor 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SNAI3 mRNA CTD PMID:17183730 NCBI chr19:55,276,211...55,290,031
Ensembl chr19:55,277,549...55,284,663
JBrowse link
G Snf8 SNF8 subunit of ESCRT-II multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SNF8 mRNA CTD PMID:17183730 NCBI chr10:83,856,331...83,868,621
Ensembl chr10:83,856,280...83,868,598
JBrowse link
G Snrnp70 small nuclear ribonucleoprotein U1 subunit 70 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SNRNP70 mRNA CTD PMID:17183730 NCBI chr 1:101,367,470...101,388,153
Ensembl chr 1:101,367,471...101,388,129
JBrowse link
G Snrpb small nuclear ribonucleoprotein polypeptides B and B1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SNRPB mRNA CTD PMID:17183730 NCBI chr 3:122,696,125...122,703,734
Ensembl chr 3:122,695,939...122,703,734
JBrowse link
G Snrpb2 small nuclear ribonucleoprotein polypeptide B2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SNRPB2 mRNA CTD PMID:17183730 NCBI chr 3:137,138,082...137,147,575
Ensembl chr 3:137,137,980...137,147,575
JBrowse link
G Snrpd2 small nuclear ribonucleoprotein D2 polypeptide multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SNRPD2 mRNA CTD PMID:17183730 NCBI chr 1:80,057,140...80,059,990
Ensembl chr 1:80,056,755...80,059,996
JBrowse link
G Snrpg small nuclear ribonucleoprotein polypeptide G multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SNRPG mRNA CTD PMID:17183730 NCBI chr 4:118,167,267...118,174,846
Ensembl chr 4:118,167,294...118,174,842
JBrowse link
G Snu13 small nuclear ribonucleoprotein 13 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SNU13 mRNA CTD PMID:17183730 NCBI chr 7:123,282,754...123,287,721
Ensembl chr 7:123,282,754...123,287,721
JBrowse link
G Sox1 SRY-box transcription factor 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SOX1 mRNA CTD PMID:17183730
G Sox9 SRY-box transcription factor 9 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SOX9 mRNA CTD PMID:17183730 NCBI chr10:101,288,528...101,294,030
Ensembl chr10:101,288,489...101,293,379
JBrowse link
G Spdef SAM pointed domain containing ets transcription factor multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SPDEF mRNA CTD PMID:17183730 NCBI chr20:7,292,823...7,308,053
Ensembl chr20:7,292,824...7,307,284
JBrowse link
G Spint1 serine peptidase inhibitor, Kunitz type 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SPINT1 mRNA CTD PMID:17183730 NCBI chr 3:111,049,132...111,061,991
Ensembl chr 3:111,049,118...111,062,011
JBrowse link
G Sprr1a small proline-rich protein 1A multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of SPRR1A mRNA CTD PMID:17183730 NCBI chr 2:192,669,143...192,671,059
Ensembl chr 2:192,669,143...192,671,059
JBrowse link
G Sprr1b small proline-rich protein 1B multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of SPRR1B mRNA CTD PMID:17183730 NCBI chr 2:192,622,972...192,624,848
Ensembl chr 2:192,623,244...192,623,681
JBrowse link
G Srp72 signal recognition particle 72 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SRP72 mRNA CTD PMID:17183730 NCBI chr14:33,447,583...33,453,788 JBrowse link
G Srp9 signal recognition particle 9 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SRP9 mRNA CTD PMID:17183730 NCBI chr13:100,551,307...100,559,447
Ensembl chr13:100,551,307...100,559,447
JBrowse link
G Srpk3 SRSF protein kinase 3 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SRPK3 mRNA CTD PMID:17183730 NCBI chr  X:157,008,773...157,014,342
Ensembl chr  X:157,008,824...157,013,443
JBrowse link
G Srxn1 sulfiredoxin 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SRXN1 mRNA CTD PMID:17183730 NCBI chr 3:147,608,850...147,614,410
Ensembl chr 3:147,609,095...147,632,801
JBrowse link
G Ssbp4 single stranded DNA binding protein 4 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SSBP4 mRNA CTD PMID:17183730 NCBI chr16:20,578,111...20,589,295
Ensembl chr16:20,578,131...20,589,290
JBrowse link
G Sspn sarcospan multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SSPN mRNA CTD PMID:17183730 NCBI chr 4:180,291,389...180,325,799
Ensembl chr 4:180,291,389...180,324,408
JBrowse link
G Ssr1 signal sequence receptor subunit 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SSR1 mRNA CTD PMID:17183730 NCBI chr17:27,496,369...27,512,781
Ensembl chr17:27,492,220...27,523,912
JBrowse link
G St8sia2 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of ST8SIA2 mRNA CTD PMID:17183730 NCBI chr 1:135,336,374...135,406,699
Ensembl chr 1:135,336,374...135,406,700
JBrowse link
G Stab2 stabilin 2 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of STAB2 mRNA CTD PMID:17183730 NCBI chr 7:27,369,853...27,552,078
Ensembl chr 7:27,369,853...27,552,078
JBrowse link
G Stag1 stromal antigen 1 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of STAG1 mRNA CTD PMID:17183730 NCBI chr 8:108,958,099...109,342,738
Ensembl chr 8:108,958,046...109,342,738
JBrowse link
G Steap2 STEAP2 metalloreductase multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in decreased expression of STEAP2 mRNA CTD PMID:17183730 NCBI chr 4:25,506,604...25,527,088
Ensembl chr 4:25,507,463...25,527,087
JBrowse link
G Stk38 serine/threonine kinase 38 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of STK38 mRNA CTD PMID:17183730 NCBI chr20:6,224,300...6,257,613
Ensembl chr20:6,224,296...6,257,604
JBrowse link
G Stx11 syntaxin 11 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of STX11 mRNA CTD PMID:17183730 NCBI chr 1:7,039,160...7,064,870
Ensembl chr 1:7,039,162...7,064,870
JBrowse link
G Stx5 syntaxin 5 multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of STX5 mRNA CTD PMID:17183730 NCBI chr 1:224,939,497...224,955,658
Ensembl chr 1:224,939,497...224,955,657
JBrowse link
G Styx serine/threonine/tyrosine interacting protein multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of STYX mRNA CTD PMID:17183730 NCBI chr15:19,690,079...19,720,683
Ensembl chr15:19,690,194...19,717,774
JBrowse link
G Sufu SUFU negative regulator of hedgehog signaling multiple interactions ISO [Hydralazine co-treated with Valproic Acid] results in increased expression of SUFU mRNA CTD PMID:17183730 NCBI chr 1:266,143,766...266,241,742
Ensembl chr 1:266,143,818...266,239,016
JBrowse link
G Sumo3 small ubiquiti